pfizer (biotechcompany)

literal strings:
  PFIZER, Pfizer, pfizer
  PFIZER INC, pfizer_inc, Pfizer Inc, pfizer inc

Help NELL Learn!

NELL wants to know if these beliefs are correct.
If they are or ever were, click thumbs-up. Otherwise, click thumbs-down.

• pfizer is a biotech company     
• pfizer is a company     
• pfizer has human agency     
• pfizer has acquired pharmacia (biotechcompany)     
• pfizer has acquired wyeth_ayerst (biotechcompany)     
• pfizer has acquired warner_lambert (biotechcompany)     
• pfizer has acquired parke_davis (biotechcompany)     

categories

• biotechcompany(100.0%)
• Seed
• CPL @1113 (54.8%) on 02-aug-2018 [ "honorarium from _" "It is marketed by _" "pharmaceutical companies such as _" "speaker fees from _" "_ is a pharmaceutical company" "drug companies such as _" "drug developed by _" "biotechnology companies like _" "educational grant from _" "drug manufactured by _" "in-licensing agreement with _" "_ is a biopharmaceutical company" "patent held by _" "pharmaceutical company such as _" "_ filed a new drug application" "unrestricted grant from _" "_ announced FDA approval" "research grant support from _" "placebo were provided by _" "trademark , of _" "business unit of _" "Viagra is manufactured by _" "drug made by _" "trial was funded by _" "_ holds the patent" "pharmaceutical companies , like _" "Pharmaceutical companies such as _" "drugmakers , including _" "_ 's Sutent" "_ 's Lyrica" "_ 's experimental drug" "_ 's Celebrex" "quick guide is supported by _" "_ 's Zoloft" "_ had an annual average" "several pharmaceutical companies including _" "studies , conducted by _" "drug , manufactured by _" "animal health business of _" "_ 's Aricept" "drugs giant _" "_ 's Lipitor" "drug makers such as _" "_ 's Neurontin" "honoraria from _" "research support from _" "grant/research support from _" "educational grants from _" "registered brand name of _" "_ is seeking FDA approval" "speakers bureaus for _" "drug companies like _" "Whales playing _" "research grant funding from _" "drug being developed by _" "pharmaceutical companies including _" "second-largest player was _" "unrestricted educational grant from _" "biotechnology companies , including _" "grant support from _" "drug sold by _" "unrestricted educational grants from _" "multinational firms such as _" "investigator-initiated grant from _" "worldwide license agreement with _" "worldwide collaboration with _" "drugmakers such as _" "_ 's Viagra" "Viagra , made by _" ] using pfizer_inc
• SEAL @214 (99.6%) on 22-feb-2011 [ 1 2 3 4 5 6 7 8 ] using pfizer_inc
• OE @811 (99.0%) on 08-feb-2014 [   ] using pfizer
• OE @821 (88.1%) on 09-mar-2014 [   ] using pfizer_inc
• CMC @1070 (100.0%) on 04-aug-2017 [ LASTPREFIX=in 3.31564 LASTSUFFIX=nc 3.27268 LAST_WORD=inc 3.21353 SUFFIX=nc 3.19808 PREFIX=in 2.18282 POS=NN 0.88649 WORDSHAPE=aaa 0.87092 FULL_POS=NN_NN -1.03940 SHORT_WORDSHAPE=a -2.90538 WORDS -3.55919 ] using pfizer_inc
• CPL @1107 (75.0%) on 24-may-2018 [ "_ is the first pharmaceutical company" "grant/research support from _" "possible legal actions against _" "such notable organizations as _" "medicine is manufactured by _" "FDA has asked _" "Ritalin , manufactured by _" "detailed dividend stock ratings information for _" "_ is asking the FDA" "plaintiffs accuse _" "patent held by _" "vaccine , made by _" "drug was developed by _" "multinationals like _" "assistant scientist at _" "unrestricted grants from _" "top holdings are _" "drug giants like _" "_ transferred production" "_ s zoloft" "biotechnology companies including _" "manufacturing companies such as _" "large multinational companies such as _" "_ co-sponsored the meeting" "_ 's Global Headquarters" "VC arm of _" "Viagra , made by _" "_ 's Ann Arbor campus" "_ s lipitor" "_ is an Inside Value" "_ has exclusive worldwide rights" "_ has recalled over" "grants/research support from _" "_ 's original patent" "_ 's diabetes drug" "_ 's Nexavar" "commercial positions at _" "_ 's marketing dollars" "NOA to _" "_ was the first pharmaceutical company" "FDA required _" "Prize , sponsored by _" "pharmaceutical firms including _" "_ 's original drug" "_ filed a new drug application" "_ has filed a patent infringement suit" "major corporations such as _" "medication is made by _" "_ 's Bextra" "_ 's new treatment" "senior business development positions at _" "pharmaceutical industry like _" "_ 's cholesterol drug" "_ 's global research" "Class action lawsuit filed against _" "_ received an approvable letter" "_ said GENERIC DRUG" "_ 's worldwide organization" "multi-nationals such as _" "drug sold by _" "disclosure sent _" "powder was obtained from _" "_ 's cancer drug" "drug is being developed by _" "_ is a Motley Fool Income Investor pick" "pharma like _" "successful DD-year career at _" "It is manufactured by _" "_ 's marketing strength" "free online program from _" "_ recently launched a site" "_ 's U.S. Patent No." "Pharmaceutical companies , including _" "Healthcare division of _" "Watson laboratories inc _" "Job cuts at _" "milestone payments from _" "lawsuits have already been filed against _" "key clients included _" "pharmaceutical company such as _" "FDA has required _" "_ 's wonder drug" "Pharma companies like _" "_ 's Zetia" "FDA asked _" "drug designed by _" "world class companies such as _" "several industry leaders , including _" "_ has initiated a Phase" "_ committed inequitable conduct" "educational grant provided by _" "pharma companies such as _" "research chemist at _" "product , manufactured by _" "healthcare companies like _" "_ recalled the drug" "senior research chemist at _" "drug , made by _" "drug made by _" "such leading firms as _" "industrial career at _" "_ 's pipeline products" "_ 's VIAGRA" "drug company called _" "drugmakers like _" "pharmaceuticals giant _" "_ pulled the drug" "news is devastating to _" "many large corporations including _" "_ sued Apotex" "_ 's Andover" "industrial giants like _" "drug companies , including _" "drug being developed by _" "inhibitor made by _" "American firms , including _" "Industry leaders including _" "_ 's Japanese unit" "British subsidiary of _" "year was acquired by _" "unrestricted research grant from _" "_ 's animal health business" "Claims Act case against _" "_ 's proprietary compounds" "_ Distinguished Chair" "_ 's voluntary withdrawal" "_ asks FDA" "_ marketed Neurontin" "pharmaceutical rep for _" "collaboration deal with _" "drug application filed by _" "_ 's Vioxx" "outcomes research at _" "particular audiences including _" "_ 's research organization" "_ filed an NDA" "_ 's drug portfolio" "Additional financial support was provided by _" "It was patented by _" "_ has earned billions" "pharmaceutical firm of _" "renowned names as _" "drug business of _" "standards were obtained from _" "senior principal scientist at _" "Pravachol , made by _" "Drug Administration asked _" "American company like _" "treatment manufactured by _" "It is currently marketed by _" "_ 's manufacturing site" "_ is developing the drug" "drug marketed by _" "pharmacology department at _" "Pharmaceutical companies such as _" "enrollment form available please call _" "case number with _" "care companies , including _" "drug major _" "_ 's late-stage pipeline" "_ 's generic version" "consumer products division of _" "drug discovery research at _" "pharma companies including _" "_ voluntarily withdrew Vioxx" "pharmaceutical company named _" "other large companies such as _" "discovery efforts at _" "proprietary data of _" "safety monitoring boards for _" "stock shareholder in _" "overweighted position in _" "other sites produced by _" "multinationals such as _" "_ is testing the drug" "major pharmaceutical companies such as _" "View prescription medications of _" "_ 's experimental drug" "_ 's Nigerian subsidiary" "_ 's Lyrica" "_ 's Celebrex" "_ 's Central Research" "_ made an equity investment" "sleep disorder drug made by _" "_ is a global pharmaceutical" "diagnostics division of _" "_ is a Motley Fool Income Investor recommendation" "False Claims Act case against _" "_ 's Patient Assistance Program" "Resource Center , sponsored by _" "pharmaceutical representative with _" "pills made by _" "diet pill manufactured by _" "clinical development at _" "_ immediately cease the dissemination" "sciences group at _" "drugmakers , such as _" "class companies such as _" "_ reported adjusted net income" "chemical companies , including _" "drug metabolism at _" "drugs manufactured by _" "chief medical officer at _" "educational grant from _" "global company such as _" "tablets are manufactured by _" "speaking fees from _" "supplement was funded by _" "lawsuits are being filed against _" "milestone payment from _" "unrestricted grant from _" "unconditional educational grant from _" "Several manufacturers , including _" "Product Information Provided by _" "products division of _" "sales last year for _" "research support from _" "new drug developed by _" "several pharmaceutical companies , including _" "tablets , made by _" "such renowned names as _" "PLAVIX is made by _" "_ 's Aricept" "_ 's China headquarters" "_ 's Corporate Vice President" "several drug companies , including _" "medication marketed by _" "bioinformatics group at _" "_ still owns the patent" "antibiotic made by _" "_ 's Supplier Diversity Program" "_ recently launched the first" "discovery collaborations with _" "consulting fee from _" "consultancy fees from _" "_ gets FDA approval" "_ launched a trial" "corporate officer at _" "drug owned by _" "drug is distributed by _" "company acquired by _" "several management positions at _" "pharmaceutical company called _" "_ is a Motley Fool Income Investor selection" "_ make medications" "_ is an Income Investor selection" "_ 's research headquarters" "major pharmaceutical companies , including _" "corporate collections such as _" "_ 's Lipitor" "Industry leaders such as _" "_ 's second-biggest seller" "MigreLieve , made by _" "unrestricted educational grant from _" "drug development at _" "educational activities from _" "drugs giant _" "discovery research at _" "_ becoming Manager" "biotech firms , including _" "several pharmaceutical companies including _" "antidepressant manufactured by _" "_ submitted the NDA" "fine paid by _" "_ 's Global Research Center" "_ 's citizen petition" "_ 's Japan unit" "Western companies like _" "big pharmaceutical companies like _" "_ signed a licensing agreement" "pharma companies like _" "poll cited by _" "ratings information for _" "Webinar sponsored by _" "such leading companies as _" "technology licensing agreement with _" "antibiotic manufactured by _" "XR is made by _" "co-marketing agreement with _" "company now owned by _" "_ makes a drug" "_ is seeking FDA approval" "research executive at _" "research grant support from _" "_ withdrew the drug" "_ said GENERIC GENERIC DRUG" "big pharmaceutical companies such as _" "independent educational grant from _" "MNCs like _" "_ 's drug discovery programs" "drug makers such as _" "pharmaceutical firms such as _" "chemists working at _" "breaches , while _" "study was underwritten by _" "new vaccine from _" "milestone payment to _" "multinational companies such as _" "_ 's antifungal" "_ had committed inequitable conduct" "_ manufactured drug" "_ is an Inside Value selection" "consulting fees from _" "pill made by _" "pharmaceutical companies , including _" "top companies , including _" "_ 's ongoing litigation" "_ 's free cash flow margin" "Multinational companies such as _" "company he sold to _" "_ is a research-based pharmaceutical company" "former sales representative for _" "_ pioneered the mass production" "major pharmaceutical companies including _" "_ holds the marketing rights" "Viagra marketed by _" "Dividend Stock Ratings information for _" "honorariums from _" "infringement litigation between _" "medication produced by _" "major pharmaceutical companies like _" "biopharmaceutical companies such as _" "generous educational grant from _" "generic companies , including _" "_ has marketing rights" "biotech companies like _" "product innovations by _" "product liability lawsuit against _" "_ 's central research facility" "_ 's R&D facilities" "_ 's public-relations firm" "Key market players covered are _" "Corp. , acquired by _" "pill , manufactured by _" "research subsidiary of _" "independent grant from _" "major global companies such as _" "metabolic diseases at _" "medicine made by _" "such industry giants as _" "industrial placement at _" "inhibitor developed by _" "biotech companies , such as _" "_ suspend sales" "_ ends development" "patient assistance program provided by _" "_ is an outstanding partner" "_ launched Viagra" "_ informed the FDA" "_ is a free instance" "_ hopes the drug" "_ 's first manufacturing facility" "_ 's statin" "_ fda celebrex" "trial was supported by" ] using pfizer
• CMC @1105 (100.0%) on 25-mar-2018 [ SUFFIX=fizer 1.73447 LASTSUFFIX=fizer 1.72659 PREFIX=pfize 1.71274 PREFIX=pfiz 1.71274 PREFIX=pfi 1.70936 SUFFIX=zer 1.70933 LASTPREFIX=pfize 1.68915 FULL_POS=NN -1.07808 WORDS -1.11877 LASTSUFFIX=er -1.68791 ] using pfizer
• SEAL @207 (100.0%) on 12-feb-2011 [ 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 ] using pfizer
• company(100.0%)
• MBL @1116 (100.0%) on 12-sep-2018 [ Promotion of biotechcompany:pfizer competeswith biotechcompany:roche_laboratories ] using concept:biotechcompany:pfizer
• SEAL @31 (100.0%) on 25-jan-2010 [ 1 2 3 4 5 6 7 8 9 10 11 12 ] using pfizer
• Human feedback from bkisiel @840 on 23-may-2014 [ "pfizer headquarteredin new_york_city", Action=(+headquarteredin) (from NELL.08m.840.SSFeedback.csv) ] using pfizer
• MBL @1116 (100.0%) on 12-sep-2018 [ Promotion of ceo:jeff_kindler ceoof biotechcompany:pfizer ] using concept:ceo:jeff_kindler
• SEAL @628 (57.7%) on 26-aug-2012 [ 1 2 3 4 5 ] using pfizer_inc
• Seed
• MBL @1116 (100.0%) on 12-sep-2018 [ Promotion of biotechcompany:roche competeswith biotechcompany:pfizer ] using concept:biotechcompany:roche
• CMC @1095 (100.0%) on 17-jan-2018 [ LAST_WORD=inc 3.43117 LASTSUFFIX=nc 3.36828 SUFFIX=nc 3.32569 LASTPREFIX=in 1.38844 SHORT_WORDSHAPE=Aa 0.99366 SUFFIX=fizer 0.43826 PREFIX=pfize 0.43826 FULL_POS=NN_NN -0.76052 FULL_WORDSHAPE=a_a -1.64996 CHARS -1.91510 ] using pfizer_inc
• OE @947 (85.6%) on 04-sep-2015 [ http://topics.nytimes.com/top/news/business/companies/pfizer_inc/index.html https://twitter.com/pfizer_news http://en.wikipedia.org/wiki/Pfizer https://twitter.com/pfizer_news http://en.wikipedia.org/wiki/Pfizer http://topics.nytimes.com/top/news/business/companies/pfizer_inc/index.html https://twitter.com/pfizer_news https://twitter.com/pfizer_news http://www.usatoday.com/story/money/business/2013/05/06/pfizer-viagra-online/2138155/ http://en.wikipedia.org/wiki/Pfizer https://twitter.com/pfizer_news http://www.npr.org/blogs/health/2013/05/06/181577694/pfizer-goes-direct-with-viagra-sales-to-men http://en.wikipedia.org/wiki/Pfizer http://en.wikipedia.org/wiki/Pfizer http://en.wikipedia.org/wiki/Pfizer https://twitter.com/pfizer_news http://quotes.wsj.com/PFE https://twitter.com/pfizer_news http://www.google.com/finance?cid=664730 http://en.wikipedia.org/wiki/Pfizer http://www.pfizerfellowships.com/GrantsProgType.aspx?ProgTypeID=3 https://twitter.com/pfizer_news https://twitter.com/pfizer_news http://en.wikipedia.org/wiki/Pfizer http://www.npr.org/blogs/health/2013/05/06/181577694/pfizer-goes-direct-with-viagra-sales-to-men  ] using pfizer
• MBL @1116 (100.0%) on 12-sep-2018 [ Promotion of biotechcompany:roche_laboratories competeswith biotechcompany:pfizer ] using concept:biotechcompany:roche_laboratories
• OE @892 (94.6%) on 26-dec-2014 [ https://twitter.com/pfizer_news http://www.reuters.com/finance/stocks/overview?symbol=PFE.N http://en.wikipedia.org/wiki/Pfizer http://www.reuters.com/finance/stocks/overview?symbol=PFE.N http://www.pfizerrxpathways.com/ http://www.reuters.com/finance/stocks/overview?symbol=PFE.N http://topics.nytimes.com/top/news/business/companies/pfizer_inc/index.html http://topics.nytimes.com/top/news/business/companies/pfizer_inc/index.html http://www.bloomberg.com/quote/PFE:US http://www.pfizerrxpathways.com/ http://finance.yahoo.com/q?s=PFE http://www.reuters.com/finance/stocks/overview?symbol=PFE.N http://www.reuters.com/finance/stocks/overview?symbol=PFE.N https://twitter.com/pfizer http://topics.nytimes.com/top/news/business/companies/pfizer_inc/index.html  ] using pfizer_inc
• humanagent(100.0%)
• Seed

NELL has only weak evidence for items listed in grey

• retailstore
• SEAL @782 (52.1%) on 22-oct-2013 [ 1 ] using pfizer_inc
• SEAL @730 (67.5%) on 02-may-2013 [ 1 ] using pfizer

relations

• acquired
• pharmacia (100.0%)
• CPL @1094 (93.8%) on 01-jan-2018 [ "arg1 acquired arg2" "arg1 subsidiary arg2" "arg1 bought arg2" "arg1 and its subsidiary arg2" ] using (pfizer, pharmacia___upjohn)
• OE @799 (94.4%) on 25-dec-2013 [ http://corporate.findlaw.com/litigation-disputes/pfizer-pharmacia-merger-the-biggest-just-got-bigger.html http://www.nytimes.com/2002/07/15/business/pfizer-said-to-buy-large-drug-rival-in-60-billion-deal.html http://en.wikipedia.org/wiki/Pharmacia http://en.wikipedia.org/wiki/Pfizer http://en.wikipedia.org/wiki/Pfizer http://www.nytimes.com/2002/07/15/business/pfizer-said-to-buy-large-drug-rival-in-60-billion-deal.html http://corporate.findlaw.com/litigation-disputes/pfizer-pharmacia-merger-the-biggest-just-got-bigger.html http://www.nytimes.com/2002/07/15/business/pfizer-said-to-buy-large-drug-rival-in-60-billion-deal.html http://corporate.findlaw.com/litigation-disputes/pfizer-pharmacia-merger-the-biggest-just-got-bigger.html http://online.wsj.com/news/articles/SB1026684057282753560 http://articles.economictimes.indiatimes.com/2002-07-16/news/27337126_1_pharmacia-india-pharmacia-healthcare-pfizer-pharmacia http://articles.economictimes.indiatimes.com/2002-07-16/news/27337126_1_pharmacia-india-pharmacia-healthcare-pfizer-pharmacia http://en.wikipedia.org/wiki/Pfizer http://www.nytimes.com/2002/07/15/business/pfizer-said-to-buy-large-drug-rival-in-60-billion-deal.html http://www.pfizer.com/about/history/pfizer_pharmacia http://www.nytimes.com/2002/07/15/business/pfizer-said-to-buy-large-drug-rival-in-60-billion-deal.html  ] using (pfizer, pharmacia)
• CPL @1094 (100.0%) on 01-jan-2018 [ "arg1 has now bought arg2" "arg1 bought arg2" "arg1 announced that it was buying arg2" "arg1 has recently bought arg2" "arg1 recently bought arg2" "arg1 through its acquisition of arg2" "arg1 acquired arg2" "arg1 now owns arg2" "arg1 subsidiary arg2" "arg1 bought out arg2" "arg1 announced it would acquire arg2" "arg1 subsequently merged with arg2" "arg1 was acquiring arg2" "arg1 recently acquired arg2" ] using (pfizer, pharmacia)
• wyeth_ayerst (100.0%)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:worker,concept:personbelongstoorganization,concept:superpartoforganization" "Y~_X0~concept:organizationleadbyagent,concept:personbelongstoorganization,concept:superpartof" "Y~_X0~concept:organizationleadbyagent,concept:worksfor,concept:superpartof" "Y~_X0~concept:organizationleadbyagent,concept:personbelongstoorganization,concept:agentcontrols" "Y~_X0~concept:proxyof,concept:personbelongstoorganization,concept:superpartof" ] using (pfizer, wyeth_ayerst)
• warner_lambert (99.9%)
• OE @820 (91.7%) on 06-mar-2014 [   ] using (pfizer, warner_lambert)
• SEAL @355 (50.0%) on 20-jul-2011 [ 1 ] using (pfizer, warner_lambert)
• CPL @1094 (98.4%) on 01-jan-2018 [ "arg1 acquired arg2" "arg1 bought out arg2" "arg1 has acquired arg2" "arg1 which now owns arg2" "arg1 bought arg2" "arg1 which bought arg2" ] using (pfizer, warner_lambert)
• parke_davis (96.9%)
• CPL @1094 (96.9%) on 01-jan-2018 [ "arg1 has acquired arg2" "arg1 bought arg2" "arg1 when it bought arg2" "arg1 and its subsidiary arg2" "arg1 subsidiary arg2" ] using (pfizer, parke_davis)
• agentcollaborateswithagent
• jeffrey_kindler (100.0%)
• OE @878 (100.0%) on 11-oct-2014 [ http://blogs.wsj.com/juggle/2010/12/06/when-demands-of-the-job-wear-you-out/ http://enews.tufts.edu/stories/240/2006/08/14/TuftsGraduateNamedCEOofPfizer  ] using (jeffrey_kindler, pfizer)
• OE @878 (100.0%) on 11-oct-2014 [ http://blogs.wsj.com/juggle/2010/12/06/when-demands-of-the-job-wear-you-out/ http://enews.tufts.edu/stories/240/2006/08/14/TuftsGraduateNamedCEOofPfizer  ] using (pfizer, jeffrey_kindler)
• jeffrey_kindler (100.0%)
• OE @878 (100.0%) on 11-oct-2014 [ http://blogs.wsj.com/juggle/2010/12/06/when-demands-of-the-job-wear-you-out/ http://enews.tufts.edu/stories/240/2006/08/14/TuftsGraduateNamedCEOofPfizer  ] using (jeffrey_kindler, pfizer)
• OE @878 (100.0%) on 11-oct-2014 [ http://blogs.wsj.com/juggle/2010/12/06/when-demands-of-the-job-wear-you-out/ http://enews.tufts.edu/stories/240/2006/08/14/TuftsGraduateNamedCEOofPfizer  ] using (pfizer, jeffrey_kindler)
• jeff_kindler (100.0%)
• OE @1004 (98.7%) on 07-jul-2016 [ http://topics.wsj.com/person/K/jeff-b-kindler/286 http://www.pfizer.com/about/history/jeffrey_kindler http://www.fiercepharma.com/tags/jeffrey-kindler http://www.cjr.org/the_audit/fortune_has_a_dandy_read.php?page=all http://features.blogs.fortune.cnn.com/2011/07/28/pfizer-jeff-kindler-shakeup/ http://www.fiercepharma.com/tags/jeffrey-kindler http://www.cbsnews.com/news/pfizer-ceo-kindler-quits-without-fulfilling-major-goals/ http://www.cjr.org/the_audit/fortune_has_a_dandy_read.php?page=all http://features.blogs.fortune.cnn.com/2011/07/28/pfizer-jeff-kindler-shakeup/ http://features.blogs.fortune.cnn.com/2011/07/28/pfizer-jeff-kindler-shakeup/ http://features.blogs.fortune.cnn.com/2011/07/28/pfizer-jeff-kindler-shakeup/ http://features.blogs.fortune.cnn.com/2011/07/28/pfizer-jeff-kindler-shakeup/  ] using (jeff_kindler, pfizer)
• OE @1004 (98.7%) on 07-jul-2016 [ http://topics.wsj.com/person/K/jeff-b-kindler/286 http://www.pfizer.com/about/history/jeffrey_kindler http://www.fiercepharma.com/tags/jeffrey-kindler http://www.cjr.org/the_audit/fortune_has_a_dandy_read.php?page=all http://features.blogs.fortune.cnn.com/2011/07/28/pfizer-jeff-kindler-shakeup/ http://www.fiercepharma.com/tags/jeffrey-kindler http://www.cbsnews.com/news/pfizer-ceo-kindler-quits-without-fulfilling-major-goals/ http://www.cjr.org/the_audit/fortune_has_a_dandy_read.php?page=all http://features.blogs.fortune.cnn.com/2011/07/28/pfizer-jeff-kindler-shakeup/ http://features.blogs.fortune.cnn.com/2011/07/28/pfizer-jeff-kindler-shakeup/ http://features.blogs.fortune.cnn.com/2011/07/28/pfizer-jeff-kindler-shakeup/ http://features.blogs.fortune.cnn.com/2011/07/28/pfizer-jeff-kindler-shakeup/  ] using (pfizer, jeff_kindler)
• jeff_kindler (100.0%)
• OE @1004 (98.7%) on 07-jul-2016 [ http://topics.wsj.com/person/K/jeff-b-kindler/286 http://www.pfizer.com/about/history/jeffrey_kindler http://www.fiercepharma.com/tags/jeffrey-kindler http://www.cjr.org/the_audit/fortune_has_a_dandy_read.php?page=all http://features.blogs.fortune.cnn.com/2011/07/28/pfizer-jeff-kindler-shakeup/ http://www.fiercepharma.com/tags/jeffrey-kindler http://www.cbsnews.com/news/pfizer-ceo-kindler-quits-without-fulfilling-major-goals/ http://www.cjr.org/the_audit/fortune_has_a_dandy_read.php?page=all http://features.blogs.fortune.cnn.com/2011/07/28/pfizer-jeff-kindler-shakeup/ http://features.blogs.fortune.cnn.com/2011/07/28/pfizer-jeff-kindler-shakeup/ http://features.blogs.fortune.cnn.com/2011/07/28/pfizer-jeff-kindler-shakeup/ http://features.blogs.fortune.cnn.com/2011/07/28/pfizer-jeff-kindler-shakeup/  ] using (jeff_kindler, pfizer)
• OE @1004 (98.7%) on 07-jul-2016 [ http://topics.wsj.com/person/K/jeff-b-kindler/286 http://www.pfizer.com/about/history/jeffrey_kindler http://www.fiercepharma.com/tags/jeffrey-kindler http://www.cjr.org/the_audit/fortune_has_a_dandy_read.php?page=all http://features.blogs.fortune.cnn.com/2011/07/28/pfizer-jeff-kindler-shakeup/ http://www.fiercepharma.com/tags/jeffrey-kindler http://www.cbsnews.com/news/pfizer-ceo-kindler-quits-without-fulfilling-major-goals/ http://www.cjr.org/the_audit/fortune_has_a_dandy_read.php?page=all http://features.blogs.fortune.cnn.com/2011/07/28/pfizer-jeff-kindler-shakeup/ http://features.blogs.fortune.cnn.com/2011/07/28/pfizer-jeff-kindler-shakeup/ http://features.blogs.fortune.cnn.com/2011/07/28/pfizer-jeff-kindler-shakeup/ http://features.blogs.fortune.cnn.com/2011/07/28/pfizer-jeff-kindler-shakeup/  ] using (pfizer, jeff_kindler)
• agentcompeteswithagent
• roche_laboratories (100.0%)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agenthierarchicallyaboveagent,concept:agentcontrols,concept:agentcompeteswithagent" "Y~_X0~concept:agentcontrols,concept:agentcontrols,concept:agentcompeteswithagent" "Y~_X0~concept:superpartof,concept:agentcontrols,concept:agentcompeteswithagent" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcollaborateswithagent,concept:agentcompeteswithagent" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcontrols,concept:agentcompeteswithagent" ] using (roche_laboratories, pfizer)
• OE @1104 (96.2%) on 18-mar-2018 [ http://www.uptodate.com/contents/rheumatology/peer-reviewers?topicId=2 https://idsa.confex.com/idsa/2007/webprogram/Paper24519.html http://www.jnccn.org/content/11/5S/649.abstract http://www.jnccn.org/content/11/5S/649.abstract http://acrabstracts.org/abstract/tocilizumab-combination-therapy-or-monotherapy-or-methotrexate-monotherapy-in-methotrexate-naive-patients-with-early-rheumatoid-arthritis-2-year-clinical-and-radiographic-results-from-a-randomized-p/ http://www.hematology.org/Annual-Meeting/FSS/2945.aspx https://idsa.confex.com/idsa/2007/webprogram/Paper24519.html http://www.uptodate.com/contents/rheumatology/peer-reviewers?topicId=2 http://www.thebody.com/content/art39682.html http://www.hcv-trials.com/faculty-and-disclosure.asp  ] using (pfizer, roche_laboratories)
• OE @1104 (96.2%) on 18-mar-2018 [ http://www.uptodate.com/contents/rheumatology/peer-reviewers?topicId=2 https://idsa.confex.com/idsa/2007/webprogram/Paper24519.html http://www.jnccn.org/content/11/5S/649.abstract http://www.jnccn.org/content/11/5S/649.abstract http://acrabstracts.org/abstract/tocilizumab-combination-therapy-or-monotherapy-or-methotrexate-monotherapy-in-methotrexate-naive-patients-with-early-rheumatoid-arthritis-2-year-clinical-and-radiographic-results-from-a-randomized-p/ http://www.hematology.org/Annual-Meeting/FSS/2945.aspx https://idsa.confex.com/idsa/2007/webprogram/Paper24519.html http://www.uptodate.com/contents/rheumatology/peer-reviewers?topicId=2 http://www.thebody.com/content/art39682.html http://www.hcv-trials.com/faculty-and-disclosure.asp  ] using (roche_laboratories, pfizer)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agenthierarchicallyaboveagent,concept:agentcontrols,concept:agentcompeteswithagent" "Y~_X0~concept:agentcontrols,concept:agentcontrols,concept:agentcompeteswithagent" "Y~_X0~concept:superpartof,concept:agentcontrols,concept:agentcompeteswithagent" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcollaborateswithagent,concept:agentcompeteswithagent" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcontrols,concept:agentcompeteswithagent" ] using (pfizer, roche_laboratories)
• roche_laboratories (100.0%)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agenthierarchicallyaboveagent,concept:agentcontrols,concept:agentcompeteswithagent" "Y~_X0~concept:agentcontrols,concept:agentcontrols,concept:agentcompeteswithagent" "Y~_X0~concept:superpartof,concept:agentcontrols,concept:agentcompeteswithagent" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcollaborateswithagent,concept:agentcompeteswithagent" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcontrols,concept:agentcompeteswithagent" ] using (roche_laboratories, pfizer)
• OE @1104 (96.2%) on 18-mar-2018 [ http://www.uptodate.com/contents/rheumatology/peer-reviewers?topicId=2 https://idsa.confex.com/idsa/2007/webprogram/Paper24519.html http://www.jnccn.org/content/11/5S/649.abstract http://www.jnccn.org/content/11/5S/649.abstract http://acrabstracts.org/abstract/tocilizumab-combination-therapy-or-monotherapy-or-methotrexate-monotherapy-in-methotrexate-naive-patients-with-early-rheumatoid-arthritis-2-year-clinical-and-radiographic-results-from-a-randomized-p/ http://www.hematology.org/Annual-Meeting/FSS/2945.aspx https://idsa.confex.com/idsa/2007/webprogram/Paper24519.html http://www.uptodate.com/contents/rheumatology/peer-reviewers?topicId=2 http://www.thebody.com/content/art39682.html http://www.hcv-trials.com/faculty-and-disclosure.asp  ] using (pfizer, roche_laboratories)
• OE @1104 (96.2%) on 18-mar-2018 [ http://www.uptodate.com/contents/rheumatology/peer-reviewers?topicId=2 https://idsa.confex.com/idsa/2007/webprogram/Paper24519.html http://www.jnccn.org/content/11/5S/649.abstract http://www.jnccn.org/content/11/5S/649.abstract http://acrabstracts.org/abstract/tocilizumab-combination-therapy-or-monotherapy-or-methotrexate-monotherapy-in-methotrexate-naive-patients-with-early-rheumatoid-arthritis-2-year-clinical-and-radiographic-results-from-a-randomized-p/ http://www.hematology.org/Annual-Meeting/FSS/2945.aspx https://idsa.confex.com/idsa/2007/webprogram/Paper24519.html http://www.uptodate.com/contents/rheumatology/peer-reviewers?topicId=2 http://www.thebody.com/content/art39682.html http://www.hcv-trials.com/faculty-and-disclosure.asp  ] using (roche_laboratories, pfizer)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agenthierarchicallyaboveagent,concept:agentcontrols,concept:agentcompeteswithagent" "Y~_X0~concept:agentcontrols,concept:agentcontrols,concept:agentcompeteswithagent" "Y~_X0~concept:superpartof,concept:agentcontrols,concept:agentcompeteswithagent" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcollaborateswithagent,concept:agentcompeteswithagent" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcontrols,concept:agentcompeteswithagent" ] using (pfizer, roche_laboratories)
• roche (company) (100.0%)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agenthierarchicallyaboveagent,concept:agentcontrols,concept:agentcompeteswithagent" "Y~_X0~concept:agentcontrols,concept:agentcontrols,concept:agentcompeteswithagent" "Y~_X0~concept:superpartof,concept:agentcontrols,concept:agentcompeteswithagent" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcollaborateswithagent,concept:agentcompeteswithagent" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcontrols,concept:agentcompeteswithagent" ] using (roche, pfizer)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agenthierarchicallyaboveagent,concept:agentcontrols,concept:agentcompeteswithagent" "Y~_X0~concept:agentcontrols,concept:agentcontrols,concept:agentcompeteswithagent" "Y~_X0~concept:superpartof,concept:agentcontrols,concept:agentcompeteswithagent" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcollaborateswithagent,concept:agentcompeteswithagent" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcontrols,concept:agentcompeteswithagent" ] using (pfizer, roche)
• OE @962 (100.0%) on 05-dec-2015 [ http://www.pharmatelevision.com/Video/247-Panel-Discussion-Panel-discussion--David-Rosen-Pfizer-Robert-Silverman-Roche-Jonathan-Montagu-CoNCERT-Pharmaceuticals.aspx http://www.pharmatelevision.com/Video/254-Panel-Discussion-Panel-discussion--David-Rosen-Pfizer-Robert-Silverman-Roche-Jonathan-Montagu-CoNCERT-Pharmaceuticals.aspx http://www.fiercepharma.com/story/pfizer-roche-gsk-said-be-knocking-heads-generics-eu-drug-tracking/2012-04-27 http://www.pharmatelevision.com/Video/247-Panel-Discussion-Panel-discussion--David-Rosen-Pfizer-Robert-Silverman-Roche-Jonathan-Montagu-CoNCERT-Pharmaceuticals.aspx http://www.pharmatelevision.com/Video/247-Panel-Discussion-Panel-discussion--David-Rosen-Pfizer-Robert-Silverman-Roche-Jonathan-Montagu-CoNCERT-Pharmaceuticals.aspx http://www.pharmatelevision.com/Video/254-Panel-Discussion-Panel-discussion--David-Rosen-Pfizer-Robert-Silverman-Roche-Jonathan-Montagu-CoNCERT-Pharmaceuticals.aspx http://www.pharmatelevision.com/Video/247-Panel-Discussion-Panel-discussion--David-Rosen-Pfizer-Robert-Silverman-Roche-Jonathan-Montagu-CoNCERT-Pharmaceuticals.aspx http://www.pharmatelevision.com/Video/254-Panel-Discussion-Panel-discussion--David-Rosen-Pfizer-Robert-Silverman-Roche-Jonathan-Montagu-CoNCERT-Pharmaceuticals.aspx http://www.forbes.com/sites/matthewherper/2012/05/07/failure-of-roche-hdl-booster-is-bad-news-for-merck-and-eli-lilly/ http://www.bloomberg.com/news/2011-08-19/roche-seeks-6-8-billion-win-on-heart-pill-where-pfizer-failed.html http://www.pharmatelevision.com/Video/247-Panel-Discussion-Panel-discussion--David-Rosen-Pfizer-Robert-Silverman-Roche-Jonathan-Montagu-CoNCERT-Pharmaceuticals.aspx  ] using (roche, pfizer)
• OE @962 (100.0%) on 05-dec-2015 [ http://www.pharmatelevision.com/Video/247-Panel-Discussion-Panel-discussion--David-Rosen-Pfizer-Robert-Silverman-Roche-Jonathan-Montagu-CoNCERT-Pharmaceuticals.aspx http://www.pharmatelevision.com/Video/254-Panel-Discussion-Panel-discussion--David-Rosen-Pfizer-Robert-Silverman-Roche-Jonathan-Montagu-CoNCERT-Pharmaceuticals.aspx http://www.fiercepharma.com/story/pfizer-roche-gsk-said-be-knocking-heads-generics-eu-drug-tracking/2012-04-27 http://www.pharmatelevision.com/Video/247-Panel-Discussion-Panel-discussion--David-Rosen-Pfizer-Robert-Silverman-Roche-Jonathan-Montagu-CoNCERT-Pharmaceuticals.aspx http://www.pharmatelevision.com/Video/247-Panel-Discussion-Panel-discussion--David-Rosen-Pfizer-Robert-Silverman-Roche-Jonathan-Montagu-CoNCERT-Pharmaceuticals.aspx http://www.pharmatelevision.com/Video/254-Panel-Discussion-Panel-discussion--David-Rosen-Pfizer-Robert-Silverman-Roche-Jonathan-Montagu-CoNCERT-Pharmaceuticals.aspx http://www.pharmatelevision.com/Video/247-Panel-Discussion-Panel-discussion--David-Rosen-Pfizer-Robert-Silverman-Roche-Jonathan-Montagu-CoNCERT-Pharmaceuticals.aspx http://www.pharmatelevision.com/Video/254-Panel-Discussion-Panel-discussion--David-Rosen-Pfizer-Robert-Silverman-Roche-Jonathan-Montagu-CoNCERT-Pharmaceuticals.aspx http://www.forbes.com/sites/matthewherper/2012/05/07/failure-of-roche-hdl-booster-is-bad-news-for-merck-and-eli-lilly/ http://www.bloomberg.com/news/2011-08-19/roche-seeks-6-8-billion-win-on-heart-pill-where-pfizer-failed.html http://www.pharmatelevision.com/Video/247-Panel-Discussion-Panel-discussion--David-Rosen-Pfizer-Robert-Silverman-Roche-Jonathan-Montagu-CoNCERT-Pharmaceuticals.aspx  ] using (pfizer, roche)
• roche (company) (100.0%)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agenthierarchicallyaboveagent,concept:agentcontrols,concept:agentcompeteswithagent" "Y~_X0~concept:agentcontrols,concept:agentcontrols,concept:agentcompeteswithagent" "Y~_X0~concept:superpartof,concept:agentcontrols,concept:agentcompeteswithagent" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcollaborateswithagent,concept:agentcompeteswithagent" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcontrols,concept:agentcompeteswithagent" ] using (roche, pfizer)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agenthierarchicallyaboveagent,concept:agentcontrols,concept:agentcompeteswithagent" "Y~_X0~concept:agentcontrols,concept:agentcontrols,concept:agentcompeteswithagent" "Y~_X0~concept:superpartof,concept:agentcontrols,concept:agentcompeteswithagent" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcollaborateswithagent,concept:agentcompeteswithagent" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcontrols,concept:agentcompeteswithagent" ] using (pfizer, roche)
• OE @962 (100.0%) on 05-dec-2015 [ http://www.pharmatelevision.com/Video/247-Panel-Discussion-Panel-discussion--David-Rosen-Pfizer-Robert-Silverman-Roche-Jonathan-Montagu-CoNCERT-Pharmaceuticals.aspx http://www.pharmatelevision.com/Video/254-Panel-Discussion-Panel-discussion--David-Rosen-Pfizer-Robert-Silverman-Roche-Jonathan-Montagu-CoNCERT-Pharmaceuticals.aspx http://www.fiercepharma.com/story/pfizer-roche-gsk-said-be-knocking-heads-generics-eu-drug-tracking/2012-04-27 http://www.pharmatelevision.com/Video/247-Panel-Discussion-Panel-discussion--David-Rosen-Pfizer-Robert-Silverman-Roche-Jonathan-Montagu-CoNCERT-Pharmaceuticals.aspx http://www.pharmatelevision.com/Video/247-Panel-Discussion-Panel-discussion--David-Rosen-Pfizer-Robert-Silverman-Roche-Jonathan-Montagu-CoNCERT-Pharmaceuticals.aspx http://www.pharmatelevision.com/Video/254-Panel-Discussion-Panel-discussion--David-Rosen-Pfizer-Robert-Silverman-Roche-Jonathan-Montagu-CoNCERT-Pharmaceuticals.aspx http://www.pharmatelevision.com/Video/247-Panel-Discussion-Panel-discussion--David-Rosen-Pfizer-Robert-Silverman-Roche-Jonathan-Montagu-CoNCERT-Pharmaceuticals.aspx http://www.pharmatelevision.com/Video/254-Panel-Discussion-Panel-discussion--David-Rosen-Pfizer-Robert-Silverman-Roche-Jonathan-Montagu-CoNCERT-Pharmaceuticals.aspx http://www.forbes.com/sites/matthewherper/2012/05/07/failure-of-roche-hdl-booster-is-bad-news-for-merck-and-eli-lilly/ http://www.bloomberg.com/news/2011-08-19/roche-seeks-6-8-billion-win-on-heart-pill-where-pfizer-failed.html http://www.pharmatelevision.com/Video/247-Panel-Discussion-Panel-discussion--David-Rosen-Pfizer-Robert-Silverman-Roche-Jonathan-Montagu-CoNCERT-Pharmaceuticals.aspx  ] using (roche, pfizer)
• OE @962 (100.0%) on 05-dec-2015 [ http://www.pharmatelevision.com/Video/247-Panel-Discussion-Panel-discussion--David-Rosen-Pfizer-Robert-Silverman-Roche-Jonathan-Montagu-CoNCERT-Pharmaceuticals.aspx http://www.pharmatelevision.com/Video/254-Panel-Discussion-Panel-discussion--David-Rosen-Pfizer-Robert-Silverman-Roche-Jonathan-Montagu-CoNCERT-Pharmaceuticals.aspx http://www.fiercepharma.com/story/pfizer-roche-gsk-said-be-knocking-heads-generics-eu-drug-tracking/2012-04-27 http://www.pharmatelevision.com/Video/247-Panel-Discussion-Panel-discussion--David-Rosen-Pfizer-Robert-Silverman-Roche-Jonathan-Montagu-CoNCERT-Pharmaceuticals.aspx http://www.pharmatelevision.com/Video/247-Panel-Discussion-Panel-discussion--David-Rosen-Pfizer-Robert-Silverman-Roche-Jonathan-Montagu-CoNCERT-Pharmaceuticals.aspx http://www.pharmatelevision.com/Video/254-Panel-Discussion-Panel-discussion--David-Rosen-Pfizer-Robert-Silverman-Roche-Jonathan-Montagu-CoNCERT-Pharmaceuticals.aspx http://www.pharmatelevision.com/Video/247-Panel-Discussion-Panel-discussion--David-Rosen-Pfizer-Robert-Silverman-Roche-Jonathan-Montagu-CoNCERT-Pharmaceuticals.aspx http://www.pharmatelevision.com/Video/254-Panel-Discussion-Panel-discussion--David-Rosen-Pfizer-Robert-Silverman-Roche-Jonathan-Montagu-CoNCERT-Pharmaceuticals.aspx http://www.forbes.com/sites/matthewherper/2012/05/07/failure-of-roche-hdl-booster-is-bad-news-for-merck-and-eli-lilly/ http://www.bloomberg.com/news/2011-08-19/roche-seeks-6-8-billion-win-on-heart-pill-where-pfizer-failed.html http://www.pharmatelevision.com/Video/247-Panel-Discussion-Panel-discussion--David-Rosen-Pfizer-Robert-Silverman-Roche-Jonathan-Montagu-CoNCERT-Pharmaceuticals.aspx  ] using (pfizer, roche)
• agentcontrols
• henry_mckinnell (100.0%)
• OE @823 (100.0%) on 17-mar-2014 [   ] using (pfizer, henry_mckinnell)
• SEAL @331 (99.9%) on 03-jul-2011 [ 1 2 3 4 5 6 7 8 9 10 ] using (pfizer, henry_mckinnell)
• jeff_kindler (100.0%)
• OE @827 (100.0%) on 30-mar-2014 [   ] using (pfizer, jeff_kindler)
• jeffrey_kindler (100.0%)
• OE @878 (100.0%) on 11-oct-2014 [ http://www.bloomberg.com/news/2010-12-06/pfizer-ceo-kindler-quits-after-drugmaker-s-stock-underperforms-97-of-s-p.html http://www.bbc.co.uk/news/business-11924216 http://topics.wsj.com/person/K/jeff-b-kindler/286 http://blogs.hbr.org/2009/01/is-pfizers-jeffrey-kindle-brav/  ] using (pfizer, jeffrey_kindler)
• agentinvolvedwithitem
• lipitor (drug) (100.0%)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentcreated" "Y~X0~concept:agentcreated" "Y~X0~concept:agentcreated,concept:producedby,concept:agentcreated" "Y~X0~concept:agentcreated,concept:iteminvolvedwithagent,concept:agentcreated" "Y~_X0~concept:agentcreated,concept:producedby,concept:producesproduct" ] using (pfizer, lipitor)
• CPL @1107 (50.0%) on 24-may-2018 [ "arg1 under the trade name arg2" ] using (pfizer, lipitor)
• OE @970 (100.0%) on 09-jan-2016 [ http://www.medicalnewstoday.com/articles/238542.php http://www.webmd.com/cholesterol-management/news/20111129/faq-generic-lipitor http://www.medicalnewstoday.com/articles/238542.php http://www.huffingtonpost.com/2011/11/29/lipitor-generic-pfizer_n_1119364.html http://online.wsj.com/article/SB10001424052702304550004577510613860845578.html http://online.wsj.com/article/SB10001424052702304550004577510613860845578.html http://en.wikipedia.org/wiki/Pfizer http://www.news-medical.net/health/Lipitor-What-is-Lipitor-(Spanish).aspx http://www.pubpat.org/pfizerlipitor.htm http://www.huffingtonpost.com/2011/11/29/lipitor-generic-pfizer_n_1119364.html http://www.news-medical.net/health/Lipitor-What-is-Lipitor.aspx http://www.huffingtonpost.com/2011/11/29/lipitor-generic-pfizer_n_1119364.html http://en.wikipedia.org/wiki/Pfizer http://www.webmd.com/cholesterol-management/news/20111129/faq-generic-lipitor http://www.news-medical.net/health/Lipitor-What-is-Lipitor-(Spanish).aspx http://www.news-medical.net/health/Lipitor-What-is-Lipitor.aspx http://articles.latimes.com/2012/jan/16/health/la-he-lipitor-generic-20120116 http://articles.latimes.com/2012/jan/16/health/la-he-lipitor-generic-20120116 http://www.webmd.com/cholesterol-management/news/20111129/faq-generic-lipitor http://www.medicalnewstoday.com/articles/238542.php  ] using (pfizer, lipitor)
• agentworkedondrug
• atorvastatin (100.0%)
• SEAL @878 (100.0%) on 10-oct-2014 [ 1 2 3 ] using (atorvastatin, pfizer)
• CPL @1094 (75.0%) on 01-jan-2018 [ "arg1 marketed by arg2" "arg1 is currently marketed by arg2" ] using (atorvastatin, pfizer)
• bextra (drug) (100.0%)
• SEAL @241 (50.0%) on 22-apr-2011 [ 1 ] using (bextra, pfizer)
• OE @809 (86.8%) on 01-feb-2014 [   ] using (bextra, pfizer)
• CPL @1094 (100.0%) on 01-jan-2018 [ "arg2 voluntarily withdraw arg1" "arg2 voluntarily removed arg1" "arg2 Celebrex and arg1" "arg2 voluntarily pulled arg1" "arg2 for its promotion of arg1" "arg2 to officially remove arg1" "arg2 to halt sales of arg1" "arg2 promoted the use of arg1" "arg2 has not recalled arg1" "arg2 asked the FDA to approve arg1" "arg2 suspends sales of arg1" "arg2 to voluntarily remove arg1" "arg2 is the company that manufactures arg1" "arg2 voluntarily withdrew arg1" "arg2 suspended sales of arg1" "arg2 to voluntarily withdraw arg1" "arg2 improperly promoted arg1" "arg2 eventually pulled arg1" ] using (bextra, pfizer)
• cetirizine (100.0%)
• SEAL @623 (100.0%) on 10-aug-2012 [ 1 2 ] using (cetirizine, pfizer)
• OE @826 (96.6%) on 28-mar-2014 [  ] using (cetirizine, pfizer)
• depo_provera (100.0%)
• SEAL @263 (100.0%) on 22-may-2011 [ 1 2 3 ] using (depo_provera, pfizer)
• CPL @1094 (75.0%) on 01-jan-2018 [ "arg1 lawsuit also alleges that arg2" "arg1 is manufactured by arg2" ] using (depo_provera, pfizer)
• farmorubicin (100.0%)
• SEAL @269 (100.0%) on 24-may-2011 [ 1 2 3 ] using (farmorubicin, pfizer)
• fluconazole (100.0%)
• SEAL @623 (100.0%) on 10-aug-2012 [ 1 2 ] using (fluconazole, pfizer)
• CPL @1094 (50.0%) on 01-jan-2018 [ "arg1 is manufactured by arg2" ] using (fluconazole, pfizer)
• fosphenytoin (100.0%)
• SEAL @623 (100.0%) on 10-aug-2012 [ 1 2 ] using (fosphenytoin, pfizer)
• OE @805 (96.8%) on 20-jan-2014 [   ] using (fosphenytoin, pfizer)
• methotrexate (100.0%)
• SEAL @523 (100.0%) on 02-mar-2012 [ 1 2 3 ] using (methotrexate, pfizer)
• viagra (100.0%)
• SEAL @209 (98.4%) on 14-feb-2011 [ 1 2 3 4 5 6 ] using (viagra, pfizer)
• Seed
• OE @1027 (99.2%) on 13-nov-2016 [ http://www.viagra.com/ http://www.viagra.com/ http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0b0be196-0c62-461c-94f4-9a35339b4501 http://www.philly.com/philly/blogs/phillypharma/Pfizer-goes-online-with-Viagra-potentially-changing-pharmaceutical-supply-chain-dynamics.html  ] using (viagra, pfizer_inc)
• CPL @1094 (99.9%) on 01-jan-2018 [ "arg1 is manufactured by arg2" "arg1 is a drug manufactured by arg2" "arg1 About What does arg2" "arg1 marketed by arg2" "arg1 is marketed by arg2" "arg1 was first manufactured by arg2" "arg1 lawsuit alleges that arg2" "arg1 is a drug developed by arg2" "arg1 Manufactured by arg2" "arg1 is manufactured and marketed by arg2" ] using (viagra, pfizer)
• CPL @1094 (87.5%) on 01-jan-2018 [ "arg2 decided to market arg1" "arg2 under the brand name arg1" "arg2 holds the patent for arg1" ] using (viagra, pfizer_inc)
• OE @1051 (100.0%) on 20-apr-2017 [ http://www.viagra.com/ http://www.viagra.com/ http://en.wikipedia.org/wiki/Sildenafil http://www.pfizer.com/files/products/uspi_viagra.pdf http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0b0be196-0c62-461c-94f4-9a35339b4501 http://en.wikipedia.org/wiki/Sildenafil http://www.viagral.com/brand-viagra.html http://www.viagral.com/brand-viagra.html http://www.viagral.com/brand-viagra.html http://en.wikipedia.org/wiki/Sildenafil  ] using (viagra, pfizer)
• lipitor (drug) (100.0%)
• SEAL @224 (98.4%) on 24-mar-2011 [ 1 2 3 4 5 6 ] using (lipitor, pfizer)
• OE @806 (87.6%) on 23-jan-2014 [   ] using (lipitor, pfizer)
• CPL @1094 (99.2%) on 01-jan-2018 [ "arg2 under the trade name arg1" "arg2 continued to market arg1" "arg2 sells as arg1" "arg2 for its marketing of arg1" "arg2 under the brand name arg1" "arg2 could begin to market arg1" "arg2 conducted a study comparing arg1" ] using (lipitor, pfizer)
• neurontin (100.0%)
• SEAL @236 (87.5%) on 16-apr-2011 [ 1 2 3 ] using (neurontin, pfizer)
• CPL @1094 (99.8%) on 01-jan-2018 [ "arg2 fraudulently marketed arg1" "arg2 illegally promoted arg1" "arg2 epilepsy drug arg1" "arg2 had marketed arg1" "arg2 under the brand name arg1" "arg2 is currently marketing arg1" "arg2 promoted the use of arg1" "arg2 received approval for arg1" "arg2 illegally marketed arg1" ] using (neurontin, pfizer)
• zoloft (100.0%)
• CPL @1094 (98.4%) on 01-jan-2018 [ "arg1 is manufactured and marketed by arg2" "arg1 marketed by arg2" "arg1 is being manufactured by arg2" "arg1 which is manufactured by arg2" "arg1 was first manufactured by arg2" "arg1 is manufactured by arg2" ] using (zoloft, pfizer)
• SEAL @221 (96.9%) on 18-mar-2011 [ 1 2 3 4 5 ] using (zoloft, pfizer)
• norvasc (99.9%)
• CPL @1094 (96.9%) on 01-jan-2018 [ "arg2 under the brand name arg1" "arg2 owns the patent to arg1" "arg2 blood pressure treatment arg1" "arg2 patent protection on arg1" "arg2 under the trade name arg1" ] using (norvasc, pfizer)
• SEAL @221 (96.9%) on 18-mar-2011 [ 1 2 3 4 5 ] using (norvasc, pfizer)
• sutent (99.9%)
• SEAL @209 (99.2%) on 14-feb-2011 [ 1 2 3 4 5 6 7 ] using (sutent, pfizer)
• CPL @1094 (87.5%) on 01-jan-2018 [ "arg1 is marketed by arg2" "arg1 is currently marketed by arg2" "arg1 is manufactured by arg2" ] using (sutent, pfizer)
• aromasin (99.8%)
• SEAL @248 (99.6%) on 12-may-2011 [ 1 2 3 4 5 6 7 8 ] using (aromasin, pfizer)
• CPL @1094 (50.0%) on 01-jan-2018 [ "arg1 is manufactured by arg2" ] using (aromasin, pfizer)
• chantix (99.6%)
• SEAL @209 (87.5%) on 14-feb-2011 [ 1 2 3 ] using (chantix, pfizer)
• SEAL @310 (75.0%) on 21-jun-2011 [ 1 2 ] using (chantix, pfizer_inc)
• CPL @1094 (96.9%) on 01-jan-2018 [ "arg1 was discovered and developed by arg2" "arg1 is marketed by arg2" "arg1 is manufactured by arg2" "arg1 is manufactured and distributed by arg2" "arg1 class action lawsuits against arg2" ] using (chantix, pfizer)
• diflucan (99.6%)
• CPL @1094 (50.0%) on 01-jan-2018 [ "arg1 is manufactured by arg2" ] using (diflucan, pfizer)
• SEAL @224 (99.2%) on 24-mar-2011 [ 1 2 3 4 5 6 7 ] using (diflucan, pfizer)
• celebrex (98.4%)
• CPL @1094 (75.0%) on 01-jan-2018 [ "arg1 is manufactured by arg2" "arg1 is marketed by arg2" ] using (celebrex, pfizer)
• SEAL @584 (75.0%) on 01-jun-2012 [ 1 2 ] using (celebrex, pfizer_inc)
• SEAL @236 (93.8%) on 16-apr-2011 [ 1 2 3 4 ] using (celebrex, pfizer)
• zithromax (98.4%)
• CPL @1094 (75.0%) on 01-jan-2018 [ "arg2 under the brand name arg1" "arg2 and offered for sale as arg1" ] using (zithromax, pfizer)
• SEAL @224 (93.8%) on 24-mar-2011 [ 1 2 3 4 ] using (zithromax, pfizer)
• camptosar (96.9%)
• SEAL @310 (96.9%) on 21-jun-2011 [ 1 2 3 4 5 ] using (camptosar, pfizer)
• SEAL @575 (50.0%) on 22-may-2012 [ 1 ] using (camptosar, pfizer_inc)
• cardura (96.9%)
• CPL @1094 (50.0%) on 01-jan-2018 [ "arg1 was first manufactured by arg2" ] using (cardura, pfizer)
• SEAL @236 (93.8%) on 16-apr-2011 [ 1 2 3 4 ] using (cardura, pfizer)
• champix (96.9%)
• CPL @1094 (87.5%) on 01-jan-2018 [ "arg2 under the brand name arg1" "arg2 discovered and developed arg1" "arg2 under the trade name arg1" ] using (champix, pfizer)
• SEAL @236 (75.0%) on 16-apr-2011 [ 1 2 ] using (champix, pfizer)
• accupril (93.8%)
• SEAL @224 (87.5%) on 24-mar-2011 [ 1 2 3 ] using (accupril, pfizer)
• CPL @1097 (50.0%) on 19-jan-2018 [ "arg1 is manufactured by arg2" ] using (accupril, pfizer)
• aricept (93.8%)
• CPL @1094 (50.0%) on 01-jan-2018 [ "arg2 under the brand name arg1" ] using (aricept, pfizer)
• SEAL @241 (87.5%) on 22-apr-2011 [ 1 2 3 ] using (aricept, pfizer)
• ellence (93.8%)
• SEAL @575 (50.0%) on 22-may-2012 [ 1 ] using (ellence, pfizer_inc)
• CPL @1094 (75.0%) on 01-jan-2018 [ "arg2 under the brand name arg1" "arg2 under the trade name arg1" ] using (ellence, pfizer)
• SEAL @305 (75.0%) on 19-jun-2011 [ 1 2 ] using (ellence, pfizer)
• geodon (93.8%)
• CPL @1094 (50.0%) on 01-jan-2018 [ "arg1 is manufactured by arg2" ] using (geodon, pfizer)
• SEAL @575 (50.0%) on 22-may-2012 [ 1 ] using (geodon, pfizer_inc)
• SEAL @224 (87.5%) on 24-mar-2011 [ 1 2 3 ] using (geodon, pfizer)
• provera (93.8%)
• CPL @1094 (75.0%) on 01-jan-2018 [ "arg1 is manufactured by arg2" "arg1 was first manufactured by arg2" ] using (provera, pfizer)
• SEAL @263 (75.0%) on 22-may-2011 [ 1 2 ] using (provera, pfizer)
• relpax (93.8%)
• CPL @1094 (50.0%) on 01-jan-2018 [ "arg1 is manufactured by arg2" ] using (relpax, pfizer)
• SEAL @236 (50.0%) on 16-apr-2011 [ 1 ] using (relpax, pfizer)
• SEAL @584 (75.0%) on 01-jun-2012 [ 1 2 ] using (relpax, pfizer_inc)
• sinequan (93.8%)
• CPL @1094 (75.0%) on 01-jan-2018 [ "arg2 under the brand name of arg1" "arg2 under the brand name arg1" ] using (sinequan, pfizer)
• SEAL @241 (75.0%) on 22-apr-2011 [ 1 2 ] using (sinequan, pfizer)
• viracept (93.8%)
• CPL @1094 (50.0%) on 01-jan-2018 [ "arg1 is manufactured by arg2" ] using (viracept, pfizer)
• SEAL @241 (87.5%) on 22-apr-2011 [ 1 2 3 ] using (viracept, pfizer)
• companyceo
• jeff_kindler (100.0%)
• CPL @1096 (75.0%) on 18-jan-2018 [ "arg1 is CEO of arg2" "arg1 is Chairman and CEO of arg2" ] using (jeff_kindler, pfizer)
• SEAL @214 (50.0%) on 22-feb-2011 [ 1 ] using (jeff_kindler, pfizer)
• SEAL @524 (75.0%) on 04-mar-2012 [ 1 2 ] using (jeffrey_b__kindler, pfizer)
• OE @821 (100.0%) on 09-mar-2014 [   ] using (jeff_kindler, pfizer)
• companyeconomicsector
• pharmaceuticals (economicsector) (100.0%)
• Seed
• CPL @1108 (50.0%) on 07-jun-2018 [ "arg1 is the largest manufacturer of arg2" ] using (pfizer, pharmaceuticals)
• SEAL @167 (100.0%) on 17-nov-2010 [ 1 2 3 4 5 6 7 8 9 10 11 12 ] using (pfizer, pharmaceuticals)
• OE @805 (100.0%) on 20-jan-2014 [   ] using (pfizer, pharmaceuticals)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentinteractswithagent,concept:personbelongstoorganization,concept:companyeconomicsector" "Y~_X0~concept:agentcollaborateswithagent,concept:personbelongstoorganization,concept:companyeconomicsector" "Y~_X0~concept:agentinteractswithagent,concept:worksfor,concept:companyeconomicsector" "Y~_X0~concept:agentcollaborateswithagent,concept:worksfor,concept:companyeconomicsector" "Y~_X0~concept:agentinteractswithagent,concept:agentinteractswithagent,concept:companyeconomicsector" ] using (pfizer, pharmaceuticals)
• competeswith
• roche_laboratories (100.0%)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentcollaborateswithagent,concept:proxyfor,concept:competeswith" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcontrols,concept:competeswith" "Y~_X0~concept:agentcollaborateswithagent,concept:agentleadsorganization,concept:competeswith" "Y~_X0~concept:worker,concept:proxyfor,concept:competeswith" "Y~_X0~concept:organizationhasperson,concept:proxyfor,concept:competeswith" ] using (pfizer, roche_laboratories)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentcollaborateswithagent,concept:proxyfor,concept:competeswith" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcontrols,concept:competeswith" "Y~_X0~concept:agentcollaborateswithagent,concept:agentleadsorganization,concept:competeswith" "Y~_X0~concept:worker,concept:proxyfor,concept:competeswith" "Y~_X0~concept:organizationhasperson,concept:proxyfor,concept:competeswith" ] using (roche_laboratories, pfizer)
• roche_laboratories (100.0%)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentcollaborateswithagent,concept:proxyfor,concept:competeswith" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcontrols,concept:competeswith" "Y~_X0~concept:agentcollaborateswithagent,concept:agentleadsorganization,concept:competeswith" "Y~_X0~concept:worker,concept:proxyfor,concept:competeswith" "Y~_X0~concept:organizationhasperson,concept:proxyfor,concept:competeswith" ] using (pfizer, roche_laboratories)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentcollaborateswithagent,concept:proxyfor,concept:competeswith" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcontrols,concept:competeswith" "Y~_X0~concept:agentcollaborateswithagent,concept:agentleadsorganization,concept:competeswith" "Y~_X0~concept:worker,concept:proxyfor,concept:competeswith" "Y~_X0~concept:organizationhasperson,concept:proxyfor,concept:competeswith" ] using (roche_laboratories, pfizer)
• roche (company) (100.0%)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentcollaborateswithagent,concept:proxyfor,concept:competeswith" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcontrols,concept:competeswith" "Y~_X0~concept:agentcollaborateswithagent,concept:agentleadsorganization,concept:competeswith" "Y~_X0~concept:worker,concept:proxyfor,concept:competeswith" "Y~_X0~concept:organizationhasperson,concept:proxyfor,concept:competeswith" ] using (pfizer, roche)
• SEAL @623 (100.0%) on 10-aug-2012 [ 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 ] using (pfizer, roche)
• Seed
• OE @803 (99.1%) on 13-jan-2014 [   ] using (roche, pfizer)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentcollaborateswithagent,concept:proxyfor,concept:competeswith" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcontrols,concept:competeswith" "Y~_X0~concept:agentcollaborateswithagent,concept:agentleadsorganization,concept:competeswith" "Y~_X0~concept:worker,concept:proxyfor,concept:competeswith" "Y~_X0~concept:organizationhasperson,concept:proxyfor,concept:competeswith" ] using (roche, pfizer)
• SEAL @623 (100.0%) on 10-aug-2012 [ 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 ] using (roche, pfizer)
• Seed
• OE @803 (99.1%) on 13-jan-2014 [   ] using (pfizer, roche)
• roche (company) (100.0%)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentcollaborateswithagent,concept:proxyfor,concept:competeswith" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcontrols,concept:competeswith" "Y~_X0~concept:agentcollaborateswithagent,concept:agentleadsorganization,concept:competeswith" "Y~_X0~concept:worker,concept:proxyfor,concept:competeswith" "Y~_X0~concept:organizationhasperson,concept:proxyfor,concept:competeswith" ] using (pfizer, roche)
• SEAL @623 (100.0%) on 10-aug-2012 [ 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 ] using (pfizer, roche)
• Seed
• OE @803 (99.1%) on 13-jan-2014 [   ] using (roche, pfizer)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentcollaborateswithagent,concept:proxyfor,concept:competeswith" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcontrols,concept:competeswith" "Y~_X0~concept:agentcollaborateswithagent,concept:agentleadsorganization,concept:competeswith" "Y~_X0~concept:worker,concept:proxyfor,concept:competeswith" "Y~_X0~concept:organizationhasperson,concept:proxyfor,concept:competeswith" ] using (roche, pfizer)
• SEAL @623 (100.0%) on 10-aug-2012 [ 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 ] using (roche, pfizer)
• Seed
• OE @803 (99.1%) on 13-jan-2014 [   ] using (pfizer, roche)
• controlledbyagent
• henry_mckinnell (100.0%)
• OE @823 (100.0%) on 17-mar-2014 [   ] using (henry_mckinnell, pfizer)
• SEAL @359 (99.2%) on 23-jul-2011 [ 1 2 3 4 5 6 7 ] using (henry_mckinnell, pfizer)
• jeffrey_kindler (100.0%)
• OE @1039 (100.0%) on 02-feb-2017 [ http://enews.tufts.edu/stories/240/2006/08/14/TuftsGraduateNamedCEOofPfizer http://blogs.wsj.com/juggle/2010/12/06/when-demands-of-the-job-wear-you-out/  ] using (jeffrey_kindler, pfizer)
• hasofficeincity
• new_york (city) (100.0%)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:organizationheadquarteredincity" "Y~X0~concept:organizationheadquarteredincity,concept:companiesheadquarteredhere,concept:organizationheadquarteredincity" "Y~_z-concept:country:usa~concept:countrystates,concept:statecontainscity" "Y~X0~concept:organizationheadquarteredincity,concept:proxyfor,concept:proxyof" "Y~X0~concept:organizationheadquarteredincity,concept:proxyfor,concept:mutualproxyfor" ] using (pfizer, new_york)
• OE @878 (99.2%) on 11-oct-2014 [ http://topics.nytimes.com/top/news/business/companies/pfizer_inc/index.html http://en.wikipedia.org/wiki/Pfizer http://en.wikipedia.org/wiki/Pfizer http://topics.nytimes.com/top/news/business/companies/pfizer_inc/index.html  ] using (pfizer, new_york)
• SEAL @36 (50.0%) on 27-jan-2010 [ 1 ] using (pfizer, new_york)
• nueva_york (city) (100.0%)
• OE @962 (100.0%) on 05-dec-2015 [ http://www.businesswire.com/news/home/20110125006020/en/Pfizer-Announces-York-City%E2%80%99s-Top-Research-Hospitals http://www.businesswire.com/news/home/20110125006020/en/Pfizer-Announces-York-City%E2%80%99s-Top-Research-Hospitals http://www.businesswire.com/news/home/20110125006020/en/Pfizer-Announces-York-City%E2%80%99s-Top-Research-Hospitals http://www.businesswire.com/news/home/20110125006020/en/Pfizer-Announces-York-City%E2%80%99s-Top-Research-Hospitals http://en.wikipedia.org/wiki/Pfizer  ] using (pfizer, new_york_city)
• CPL @1107 (75.0%) on 24-may-2018 [ "arg1 world headquarters in arg2" "arg1 corporate headquarters in arg2" ] using (pfizer, new_york_city)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:organizationheadquarteredincity" "Y~X0~concept:organizationheadquarteredincity,concept:companiesheadquarteredhere,concept:organizationheadquarteredincity" "Y~_z-concept:country:usa~concept:countrystates,concept:statecontainscity" "Y~X0~concept:organizationheadquarteredincity,concept:proxyfor,concept:proxyof" "Y~X0~concept:organizationheadquarteredincity,concept:proxyfor,concept:mutualproxyfor" ] using (pfizer, new_york_city)
• groton (98.4%)
• SEAL @213 (50.0%) on 21-feb-2011 [ 1 ] using (pfizer, groton)
• CPL @1109 (96.9%) on 12-jun-2018 [ "arg1 Central Research in arg2" "arg1 Chemical in arg2" "arg1 corporate headquarters in arg2" "arg1 Headquarters in arg2" "arg1 Global Research and Development in arg2" ] using (pfizer, groton)
• headquarteredin
• groton (100.0%)
• OE @893 (100.0%) on 30-dec-2014 [ http://en.wikipedia.org/wiki/Pfizer http://en.wikipedia.org/wiki/Pfizer  ] using (pfizer, groton)
• mutualproxyfor
• henry_mckinnell (99.6%)
• SEAL @566 (93.8%) on 12-may-2012 [ 1 2 3 4 ] using (henry_mckinnell, pfizer)
• SEAL @566 (93.8%) on 12-may-2012 [ 1 2 3 4 ] using (pfizer, henry_mckinnell)
• henry_mckinnell (99.6%)
• SEAL @566 (93.8%) on 12-may-2012 [ 1 2 3 4 ] using (henry_mckinnell, pfizer)
• SEAL @566 (93.8%) on 12-may-2012 [ 1 2 3 4 ] using (pfizer, henry_mckinnell)
• organizationhasagent
• jeffrey_kindler (100.0%)
• OE @985 (100.0%) on 17-mar-2016 [ http://enews.tufts.edu/stories/240/2006/08/14/TuftsGraduateNamedCEOofPfizer http://blogs.wsj.com/juggle/2010/12/06/when-demands-of-the-job-wear-you-out/  ] using (jeffrey_kindler, pfizer)
• jeff_kindler (99.1%)
• OE @944 (96.3%) on 08-aug-2015 [ http://www.pfizer.com/about/history/jeffrey_kindler http://topics.wsj.com/person/K/jeff-b-kindler/286 http://www.fiercepharma.com/tags/jeffrey-kindler http://www.cbsnews.com/news/pfizer-ceo-kindler-quits-without-fulfilling-major-goals/ http://features.blogs.fortune.cnn.com/2011/07/28/pfizer-jeff-kindler-shakeup/ http://www.cjr.org/the_audit/fortune_has_a_dandy_read.php?page=all http://features.blogs.fortune.cnn.com/2011/07/28/pfizer-jeff-kindler-shakeup/ http://features.blogs.fortune.cnn.com/2011/07/28/pfizer-jeff-kindler-shakeup/ http://www.fiercepharma.com/tags/jeffrey-kindler http://features.blogs.fortune.cnn.com/2011/07/28/pfizer-jeff-kindler-shakeup/ http://www.cjr.org/the_audit/fortune_has_a_dandy_read.php?page=all http://features.blogs.fortune.cnn.com/2011/07/28/pfizer-jeff-kindler-shakeup/  ] using (jeff_kindler, pfizer)
• CPL @1097 (75.0%) on 19-jan-2018 [ "arg1 is CEO of arg2" "arg1 is Chairman and CEO of arg2" ] using (jeff_kindler, pfizer)
• organizationhasperson
• henry_mckinnell (100.0%)
• OE @961 (94.6%) on 24-nov-2015 [ http://www.xconomy.com/san-diego/2013/02/27/optimer-board-ousts-ceo-brings-back-pfizers-mckinnell/ http://content.time.com/time/specials/packages/article/0,28804,1848501_1848500_1848493,00.html http://www.naturalnews.com/035441_Pfizer_executives_cover-up.html http://www.stern.nyu.edu/experience-stern/news-events/UAT_025918  ] using (henry_mckinnell, pfizer)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:personleadsorganization,concept:organizationhasperson,concept:agentleadsorganization" "Y~X0~concept:personleadsorganization,concept:organizationhastopmember,concept:agentleadsorganization" "Y~X0~concept:agentleadsorganization" "Y~X0~concept:agentrepresentsorganization" "Y~X0~concept:personleadsorganization" ] using (henry_mckinnell, pfizer)
• jeff_kindler (100.0%)
• CPL @1099 (75.0%) on 23-jan-2018 [ "arg1 is CEO of arg2" "arg1 is Chairman and CEO of arg2" ] using (jeff_kindler, pfizer)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:personleadsorganization,concept:organizationhasperson,concept:agentleadsorganization" "Y~X0~concept:personleadsorganization,concept:organizationhastopmember,concept:agentleadsorganization" "Y~X0~concept:agentleadsorganization" "Y~X0~concept:agentrepresentsorganization" "Y~X0~concept:personleadsorganization" ] using (jeffrey_b__kindler, pfizer)
• OE @821 (94.5%) on 09-mar-2014 [   ] using (jeff_kindler, pfizer)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:personleadsorganization,concept:organizationhasperson,concept:agentleadsorganization" "Y~X0~concept:personleadsorganization,concept:organizationhastopmember,concept:agentleadsorganization" "Y~X0~concept:agentleadsorganization" "Y~X0~concept:agentrepresentsorganization" "Y~X0~concept:personleadsorganization" ] using (jeff_kindler, pfizer)
• OE @961 (100.0%) on 24-nov-2015 [ http://www.businesswire.com/news/home/20090126005624/en/Pfizer-Acquire-Wyeth-Creating-Worlds-Premier-Biopharmaceutical http://www.businesswire.com/news/home/20090126005624/en/Pfizer-Acquire-Wyeth-Creating-Worlds-Premier-Biopharmaceutical http://www.businesswire.com/news/home/20090126005624/en/Pfizer-Acquire-Wyeth-Creating-Worlds-Premier-Biopharmaceutical https://www.ppdi.com/About/~/link.aspx?_id=3B74933C848E488EAAB78C9BAE6F7F2B&_z=z http://www.reuters.com/article/2010/12/06/us-pfizer-idUSTRE6B50B120101206  ] using (jeffrey_b__kindler, pfizer)
• jeffrey_kindler (100.0%)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:personleadsorganization,concept:organizationhasperson,concept:agentleadsorganization" "Y~X0~concept:personleadsorganization,concept:organizationhastopmember,concept:agentleadsorganization" "Y~X0~concept:agentleadsorganization" "Y~X0~concept:agentrepresentsorganization" "Y~X0~concept:personleadsorganization" ] using (jeffrey_kindler, pfizer)
• OE @968 (100.0%) on 29-dec-2015 [ http://enews.tufts.edu/stories/240/2006/08/14/TuftsGraduateNamedCEOofPfizer http://blogs.wsj.com/juggle/2010/12/06/when-demands-of-the-job-wear-you-out/  ] using (jeffrey_kindler, pfizer)
• organizationhastopmember
• jeff_kindler (100.0%)
• OE @880 (100.0%) on 19-oct-2014 [ http://topics.wsj.com/person/K/jeff-b-kindler/286 http://www.foxbusiness.com/topics/business/finance/CEOs/jeffrey-kindler.htm http://www.cjr.org/the_audit/fortune_has_a_dandy_read.php?page=all http://features.blogs.fortune.cnn.com/2011/07/28/pfizer-jeff-kindler-shakeup/ http://www.fiercepharma.com/tags/jeffrey-kindler http://features.blogs.fortune.cnn.com/2011/07/28/pfizer-jeff-kindler-shakeup/ http://www.fiercepharma.com/tags/jeffrey-kindler http://features.blogs.fortune.cnn.com/2011/07/28/pfizer-jeff-kindler-shakeup/ http://www.cjr.org/the_audit/fortune_has_a_dandy_read.php?page=all http://features.blogs.fortune.cnn.com/2011/07/28/pfizer-jeff-kindler-shakeup/ http://www.foxbusiness.com/topics/business/finance/CEOs/jeffrey-kindler.htm http://www.cbsnews.com/news/pfizer-ceo-kindler-quits-without-fulfilling-major-goals/ http://features.blogs.fortune.cnn.com/2011/07/28/pfizer-jeff-kindler-shakeup/  ] using (jeff_kindler, pfizer)
• CPL @1095 (75.0%) on 17-jan-2018 [ "arg1 is CEO of arg2" "arg1 is Chairman and CEO of arg2" ] using (jeff_kindler, pfizer)
• organizationheadquarteredincity
• new_york (city) (100.0%)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:hasofficeincity" "Y~X0~concept:agentinteractswithagent,concept:agentinteractswithagent,concept:organizationactsinlocation" "Y~_z-concept:country:usa~concept:geopoliticallocationcontainsstate,concept:statecontainscity" "Y~X0~concept:hasofficeincity,concept:cityhasairport,concept:atlocation" "Y~_z-concept:country:countries~concept:generalizationof,concept:countrycities" ] using (pfizer, new_york)
• OE @1104 (100.0%) on 18-mar-2018 [ http://en.wikipedia.org/wiki/Pfizer http://en.wikipedia.org/wiki/Pfizer http://topics.nytimes.com/top/news/business/companies/pfizer_inc/index.html http://topics.nytimes.com/top/news/business/companies/pfizer_inc/index.html  ] using (pfizer, new_york)
• organizationleadbyperson
• henry_mckinnell (100.0%)
• SEAL @192 (99.8%) on 24-jan-2011 [ 1 2 3 4 5 6 7 8 9 ] using (henry_mckinnell, pfizer)
• OE @823 (100.0%) on 17-mar-2014 [   ] using (henry_mckinnell, pfizer)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:personbelongstoorganization" "Y~X0~concept:personbelongstoorganization" "Y~X0~concept:personbelongstoorganization,concept:organizationleadbyperson,concept:personbelongstoorganization" "Y~X0~concept:personbelongstoorganization,concept:organizationleadbyagent,concept:personbelongstoorganization" "Y~X0~concept:personbelongstoorganization,concept:proxyof,concept:personbelongstoorganization" ] using (henry_mckinnell, pfizer)
• jeff_kindler (100.0%)
• CPL @1096 (75.0%) on 18-jan-2018 [ "arg1 is CEO of arg2" "arg1 is Chairman and CEO of arg2" ] using (jeff_kindler, pfizer)
• OE @821 (98.8%) on 09-mar-2014 [   ] using (jeff_kindler, pfizer)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:personbelongstoorganization" "Y~X0~concept:personbelongstoorganization" "Y~X0~concept:personbelongstoorganization,concept:organizationleadbyperson,concept:personbelongstoorganization" "Y~X0~concept:personbelongstoorganization,concept:organizationleadbyagent,concept:personbelongstoorganization" "Y~X0~concept:personbelongstoorganization,concept:proxyof,concept:personbelongstoorganization" ] using (jeff_kindler, pfizer)
• OE @961 (100.0%) on 24-nov-2015 [ http://www.reuters.com/article/2010/12/06/us-pfizer-idUSTRE6B50B120101206 https://www.ppdi.com/About/~/link.aspx?_id=3B74933C848E488EAAB78C9BAE6F7F2B&_z=z http://www.businesswire.com/news/home/20090126005624/en/Pfizer-Acquire-Wyeth-Creating-Worlds-Premier-Biopharmaceutical http://www.businesswire.com/news/home/20090126005624/en/Pfizer-Acquire-Wyeth-Creating-Worlds-Premier-Biopharmaceutical http://www.businesswire.com/news/home/20090126005624/en/Pfizer-Acquire-Wyeth-Creating-Worlds-Premier-Biopharmaceutical  ] using (jeffrey_b__kindler, pfizer)
• SEAL @302 (99.2%) on 18-jun-2011 [ 1 2 3 4 5 6 7 ] using (jeff_kindler, pfizer)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:personbelongstoorganization" "Y~X0~concept:personbelongstoorganization" "Y~X0~concept:personbelongstoorganization,concept:organizationleadbyperson,concept:personbelongstoorganization" "Y~X0~concept:personbelongstoorganization,concept:organizationleadbyagent,concept:personbelongstoorganization" "Y~X0~concept:personbelongstoorganization,concept:proxyof,concept:personbelongstoorganization" ] using (jeffrey_b__kindler, pfizer)
• jeffrey_kindler (100.0%)
• SEAL @563 (93.8%) on 09-may-2012 [ 1 2 3 4 ] using (jeffrey_kindler, pfizer)
• OE @826 (100.0%) on 28-mar-2014 [   ] using (jeffrey_kindler, pfizer)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:personbelongstoorganization" "Y~X0~concept:personbelongstoorganization" "Y~X0~concept:personbelongstoorganization,concept:organizationleadbyperson,concept:personbelongstoorganization" "Y~X0~concept:personbelongstoorganization,concept:organizationleadbyagent,concept:personbelongstoorganization" "Y~X0~concept:personbelongstoorganization,concept:proxyof,concept:personbelongstoorganization" ] using (jeffrey_kindler, pfizer)
• producesproduct
• lipitor (drug) (100.0%)
• Seed
• OE @806 (95.7%) on 23-jan-2014 [   ] using (pfizer, lipitor)
• proxyof
• jeffrey_kindler (100.0%)
• OE @1039 (100.0%) on 02-feb-2017 [ http://enews.tufts.edu/stories/240/2006/08/14/TuftsGraduateNamedCEOofPfizer http://blogs.wsj.com/juggle/2010/12/06/when-demands-of-the-job-wear-you-out/  ] using (jeffrey_kindler, pfizer)
• superpartoforganization
• wyeth (company) (100.0%)
• CPL @1094 (100.0%) on 01-jan-2018 [ "arg1 was bought out by arg2" "arg1 which is now owned by arg2" "arg1 is now a subsidiary of arg2" "arg1 was subsequently acquired by arg2" "arg1 is now owned by arg2" "arg1 was bought by arg2" "arg1 was recently acquired by arg2" "arg1 was acquired by arg2" "arg1 is being acquired by arg2" "arg1 which was acquired by arg2" "arg1 agreed to be acquired by arg2" "arg1 has since been acquired by arg2" ] using (wyeth, pfizer)
• worker
• henry_mckinnell (100.0%)
• SEAL @521 (87.5%) on 28-feb-2012 [ 1 2 3 ] using (henry_mckinnell, pfizer)
• OE @961 (100.0%) on 24-nov-2015 [ http://www.xconomy.com/san-diego/2013/02/27/optimer-board-ousts-ceo-brings-back-pfizers-mckinnell/ http://www.stern.nyu.edu/experience-stern/news-events/UAT_025918 http://content.time.com/time/specials/packages/article/0,28804,1848501_1848500_1848493,00.html http://www.naturalnews.com/035441_Pfizer_executives_cover-up.html  ] using (henry_mckinnell, pfizer)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:personleadsorganization,concept:worker,concept:agentleadsorganization" "Y~X0~concept:agentleadsorganization" "Y~X0~concept:agentrepresentsorganization" "Y~X0~concept:personleadsorganization" "Y~X0~concept:personleadsorganization,concept:organizationhasperson,concept:agentleadsorganization" ] using (henry_mckinnell, pfizer)
• jeff_kindler (100.0%)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:personleadsorganization,concept:worker,concept:agentleadsorganization" "Y~X0~concept:agentleadsorganization" "Y~X0~concept:agentrepresentsorganization" "Y~X0~concept:personleadsorganization" "Y~X0~concept:personleadsorganization,concept:organizationhasperson,concept:agentleadsorganization" ] using (jeff_kindler, pfizer)
• OE @827 (100.0%) on 30-mar-2014 [   ] using (jeff_kindler, pfizer)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:personleadsorganization,concept:worker,concept:agentleadsorganization" "Y~X0~concept:agentleadsorganization" "Y~X0~concept:agentrepresentsorganization" "Y~X0~concept:personleadsorganization" "Y~X0~concept:personleadsorganization,concept:organizationhasperson,concept:agentleadsorganization" ] using (jeffrey_b__kindler, pfizer)
• OE @961 (100.0%) on 24-nov-2015 [ http://www.businesswire.com/news/home/20090126005624/en/Pfizer-Acquire-Wyeth-Creating-Worlds-Premier-Biopharmaceutical http://www.businesswire.com/news/home/20090126005624/en/Pfizer-Acquire-Wyeth-Creating-Worlds-Premier-Biopharmaceutical http://www.reuters.com/article/2010/12/06/us-pfizer-idUSTRE6B50B120101206 https://www.ppdi.com/About/~/link.aspx?_id=3B74933C848E488EAAB78C9BAE6F7F2B&_z=z http://www.businesswire.com/news/home/20090126005624/en/Pfizer-Acquire-Wyeth-Creating-Worlds-Premier-Biopharmaceutical  ] using (jeffrey_b__kindler, pfizer)
• CPL @1098 (75.0%) on 21-jan-2018 [ "arg1 is CEO of arg2" "arg1 is Chairman and CEO of arg2" ] using (jeff_kindler, pfizer)
• jeffrey_kindler (100.0%)
• OE @826 (100.0%) on 28-mar-2014 [   ] using (jeffrey_kindler, pfizer)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:personleadsorganization,concept:worker,concept:agentleadsorganization" "Y~X0~concept:agentleadsorganization" "Y~X0~concept:agentrepresentsorganization" "Y~X0~concept:personleadsorganization" "Y~X0~concept:personleadsorganization,concept:organizationhasperson,concept:agentleadsorganization" ] using (jeffrey_kindler, pfizer)

NELL has only weak evidence for items listed in grey

• acquired
• agouron_pharmaceuticals
• CPL @1095 (87.5%) on 17-jan-2018 [ "arg1 subsidiary arg2" "arg1 recently purchased arg2" "arg1 acquired arg2" ] using (pfizer, agouron_pharmaceuticals)
• esperion_therapeutics
• CPL @1099 (75.0%) on 23-jan-2018 [ "arg1 announced the acquisition of arg2" "arg1 acquired arg2" ] using (pfizer, esperion_therapeutics)
• king_pharmaceuticals (biotechcompany)
• CPL @1094 (87.5%) on 01-jan-2018 [ "arg1 is acquiring arg2" "arg1 bought arg2" "arg1 completed its acquisition of arg2" ] using (pfizer, king_pharmaceuticals)
• pharmacia_upjohn
• CPL @1100 (50.0%) on 31-jan-2018 [ "arg1 acquired arg2" ] using (pfizer, pharmacia_upjohn)
• upjohn (biotechcompany)
• CPL @1096 (50.0%) on 18-jan-2018 [ "arg1 bought arg2" ] using (pfizer, upjohn)
• vicuron_pharmaceuticals
• CPL @1098 (50.0%) on 21-jan-2018 [ "arg1 bought arg2" ] using (pfizer, vicuron_pharmaceuticals)
• warner_lambert_co_
• CPL @1098 (87.5%) on 21-jan-2018 [ "arg1 when it bought arg2" "arg1 bought arg2" "arg1 acquired arg2" ] using (pfizer, warner_lambert_co_)
• wyeth (biotechcompany)
• OE @841 (89.7%) on 25-may-2014 [ http://www.sec.gov/News/PressRelease/Detail/PressRelease/1365171483696 http://www.wikinvest.com/stock/Pfizer_(PFE)/Wyeth_(WYE) http://www.wikinvest.com/stock/Pfizer_(PFE)/Wyeth_(WYE) http://en.wikipedia.org/wiki/Wyeth http://www.wikinvest.com/stock/Pfizer_(PFE)/Wyeth_(WYE) http://online.wsj.com/news/articles/SB123293456420414421 http://www.sec.gov/News/PressRelease/Detail/PressRelease/1365171483696 http://www.sec.gov/News/PressRelease/Detail/PressRelease/1365171483696 http://money.cnn.com/2009/01/26/news/companies/pfizer_wyeth/ http://money.cnn.com/2009/01/26/news/companies/pfizer_wyeth/ http://www.fiercebiotech.com/story/pfizers-megamerger-pitch-haunted-empty-promises-past/2014-05-08 http://www.businessweek.com/bwdaily/dnflash/content/jan2009/db20090126_540552.htm http://en.wikipedia.org/wiki/Wyeth http://www.pfizer.com/news/press-release/press-release-archive-detail/pfizer_subsidiary_wyeth_llc_to_redeem_5_500_notes_due_february_1_2014 http://www.businessweek.com/bwdaily/dnflash/content/jan2009/db20090126_540552.htm http://articles.economictimes.indiatimes.com/2013-11-27/news/44520986_1_pfizer-wyeth-pfizer-and-wyeth-wyeth-stock http://www.youtube.com/watch?v=32n0WQ_YX9A http://www.sec.gov/News/PressRelease/Detail/PressRelease/1365171483696 http://www.businessweek.com/bwdaily/dnflash/content/jan2009/db20090126_540552.htm  ] using (pfizer, wyeth)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:worker,concept:personbelongstoorganization,concept:superpartoforganization" "Y~_X0~concept:organizationleadbyagent,concept:personbelongstoorganization,concept:superpartof" "Y~_X0~concept:organizationleadbyagent,concept:worksfor,concept:superpartof" "Y~_X0~concept:organizationleadbyagent,concept:personbelongstoorganization,concept:agentcontrols" "Y~_X0~concept:proxyof,concept:personbelongstoorganization,concept:superpartof" ] using (pfizer, wyeth)
• CPL @1094 (100.0%) on 01-jan-2018 [ "arg1 finalized its acquisition of arg2" "arg1 and its subsidiary arg2" "arg1 bought out arg2" "arg1 is about to buy arg2" "arg1 when it acquired arg2" "arg1 agrees to buy arg2" "arg1 to Acquire arg2" "arg1 plans to merge with arg2" "arg1 recently acquired arg2" "arg1 is in talks to buy arg2" "arg1 announced that it was acquiring arg2" "arg1 when that company acquired arg2" "arg1 is acquiring arg2" "arg1 acquired arg2" "arg1 following its purchase of arg2" "arg1 has since acquired arg2" "arg1 DDDD acquisition of arg2" "arg1 has acquired arg2" "arg1 has agreed to buy arg2" "arg1 announced the acquisition of arg2" "arg1 agreed to acquire arg2" "arg1 is about to acquire arg2" "arg1 in Talks to Buy arg2" "arg1 in talks to buy arg2" "arg1 Takeover of arg2" "arg1 announced plans to acquire arg2" "arg1 Agrees to Acquire arg2" "arg1 recently bought arg2" "arg1 bought arg2" "arg1 agreed to buy arg2" "arg1 in its acquisition of arg2" ] using (pfizer, wyeth)
• king (radiostation)
• CPL @1100 (75.0%) on 31-jan-2018 [ "arg2 was acquired by arg1" "arg2 was later acquired by arg1" ] using (pfizer, king)
• king_records
• CPL @1100 (75.0%) on 31-jan-2018 [ "arg2 was acquired by arg1" "arg2 was later acquired by arg1" ] using (pfizer, king)
• king (televisionstation)
• CPL @1100 (75.0%) on 31-jan-2018 [ "arg2 was acquired by arg1" "arg2 was later acquired by arg1" ] using (pfizer, king)
• acquiredby
• shell_oil
• CPL @1115 (50.0%) on 27-aug-2018 [ "arg1 Chemical and arg2" ] using (shell, pfizer)
• agentcollaborateswithagent
• henry_mckinnell
• SEAL @458 (50.0%) on 23-nov-2011 [ 1 ] using (henry_mckinnell, pfizer)
• SEAL @458 (50.0%) on 23-nov-2011 [ 1 ] using (pfizer, henry_mckinnell)
• agentcontrols
• wyeth (biotechcompany)
• CPL @1095 (87.5%) on 17-jan-2018 [ "arg1 to Acquire arg2" "arg1 in Talks to Buy arg2" "arg1 announced plans to acquire arg2" ] using (pfizer, wyeth)
• agentinvolvedwithitem
• bextra (drug)
• CPL @1104 (75.0%) on 18-mar-2018 [ "arg1 voluntarily pulled arg2" "arg1 to voluntarily remove arg2" ] using (pfizer, bextra)
• cytotec
• CPL @1114 (50.0%) on 18-aug-2018 [ "arg1 under the trade name arg2" ] using (pfizer, cytotec)
• inspra
• CPL @1114 (50.0%) on 18-aug-2018 [ "arg1 under the trade name arg2" ] using (pfizer, inspra)
• sunitinib (drug)
• CPL @1112 (50.0%) on 20-jul-2018 [ "arg1 cut the price of arg2" ] using (pfizer, sunitinib)
• viagra
• CPL @1104 (75.0%) on 18-mar-2018 [ "arg1 Viagra and Generic arg2" "arg1 under the trade name arg2" ] using (pfizer, viagra)
• xalatan
• CPL @1109 (50.0%) on 12-jun-2018 [ "arg1 under the trade name arg2" ] using (pfizer, xalatan)
• agentworkedondrug
• arimidex
• SEAL @298 (50.0%) on 14-jun-2011 [ 1 ] using (arimidex, pfizer)
• casodex
• SEAL @298 (50.0%) on 14-jun-2011 [ 1 ] using (casodex, pfizer)
• covera_hs
• SEAL @241 (50.0%) on 22-apr-2011 [ 1 ] using (covera_hs, pfizer)
• crestor
• SEAL @298 (50.0%) on 14-jun-2011 [ 1 ] using (crestor, pfizer)
• cymbalta
• SEAL @275 (50.0%) on 30-may-2011 [ 1 ] using (cymbalta, pfizer)
• effexor
• SEAL @266 (50.0%) on 23-may-2011 [ 1 ] using (effexor, pfizer)
• gabapentin
• SEAL @224 (87.5%) on 24-mar-2011 [ 1 2 3 ] using (gabapentin, pfizer)
• metformin
• SEAL @523 (50.0%) on 02-mar-2012 [ 1 ] using (metformin, pfizer)
• rapamune
• SEAL @250 (50.0%) on 14-may-2011 [ 1 ] using (rapamune, pfizer)
• spiriva
• CPL @1104 (50.0%) on 18-mar-2018 [ "arg1 is made jointly by arg2" ] using (spiriva, pfizer)
• tenormin
• SEAL @269 (50.0%) on 24-may-2011 [ 1 ] using (tenormin, pfizer)
• topamax
• SEAL @224 (87.5%) on 24-mar-2011 [ 1 2 3 ] using (topamax, pfizer)
• vancomycin
• SEAL @523 (50.0%) on 02-mar-2012 [ 1 ] using (vancomycin, pfizer)
• vincristine
• SEAL @263 (50.0%) on 22-may-2011 [ 1 ] using (vincristine, pfizer)
• companyalsoknownas
• sony (biotechcompany)
• CPL @1099 (50.0%) on 23-jan-2018 [ "arg1 Electronics and arg2" ] using (sony, pfizer)
• CPL @1099 (50.0%) on 23-jan-2018 [ "arg1 Electronics and arg2" ] using (pfizer, sony)
• competeswith
• bristol_myers_squibb (biotechcompany)
• CPL @1115 (50.0%) on 27-aug-2018 [ "arg1 Co and arg2" ] using (bristol_myers_squibb, pfizer)
• CPL @1115 (50.0%) on 27-aug-2018 [ "arg1 Co and arg2" ] using (pfizer, bristol_myers_squibb)
• eisai (biotechcompany)
• CPL @1109 (50.0%) on 12-jun-2018 [ "arg2 Co and arg1" ] using (pfizer_inc, eisai)
• CPL @1109 (50.0%) on 12-jun-2018 [ "arg2 Co and arg1" ] using (eisai, pfizer_inc)
• journal (newspaper)
• CPL @1109 (50.0%) on 12-jun-2018 [ "arg1 and the Wall Street arg2" ] using (pfizer, journal)
• CPL @1109 (50.0%) on 12-jun-2018 [ "arg1 and the Wall Street arg2" ] using (journal, pfizer)
• journal (newspaper)
• CPL @1109 (50.0%) on 12-jun-2018 [ "arg1 and the Wall Street arg2" ] using (pfizer, journal)
• CPL @1109 (50.0%) on 12-jun-2018 [ "arg1 and the Wall Street arg2" ] using (journal, pfizer)
• journal (politicsblog)
• CPL @1109 (50.0%) on 12-jun-2018 [ "arg1 and the Wall Street arg2" ] using (pfizer, journal)
• CPL @1109 (50.0%) on 12-jun-2018 [ "arg1 and the Wall Street arg2" ] using (journal, pfizer)
• hasofficeincity
• center (city)
• CPL @1112 (50.0%) on 20-jul-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• sandwich (city)
• CPL @1100 (87.5%) on 31-jan-2018 [ "arg1 Laboratories in arg2" "arg1 Global Research and Development in arg2" "arg1 Central Research in arg2" ] using (pfizer, sandwich)
• uk (city)
• CPL @1112 (50.0%) on 20-jul-2018 [ "arg1 Central Research in arg2" ] using (pfizer, uk)
• headquarteredin
• center (city)
• CPL @1107 (50.0%) on 24-may-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• dun_laoghaire
• CPL @1105 (50.0%) on 25-mar-2018 [ "arg1 Chemical Plant in arg2" ] using (pfizer, dun_laoghaire)
• irvine (city)
• SEAL @113 (50.0%) on 03-jun-2010 [ 1 ] using (pfizer, irvine)
• new_york (city)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:agentinteractswithagent,concept:agentinteractswithagent,concept:organizationheadquarteredincity" "Y~X0~concept:agentinteractswithagent,concept:agentinteractswithagent,concept:hasofficeincity" "Y~X0~concept:agentinteractswithagent,concept:agentinteractswithagent,concept:agentactsinlocation" "Y~X0~concept:agentinteractswithagent,concept:agentinteractswithagent,concept:organizationactsinlocation" "Y~X0~concept:agentinteractswithagent,concept:agentinteractswithagent,concept:agentrelatedtolocation" ] using (pfizer, new_york)
• OE @965 (100.0%) on 17-dec-2015 [ http://en.wikipedia.org/wiki/Pfizer http://en.wikipedia.org/wiki/Pfizer http://topics.nytimes.com/top/news/business/companies/pfizer_inc/index.html http://topics.nytimes.com/top/news/business/companies/pfizer_inc/index.html  ] using (pfizer, new_york)
• SEAL @113 (75.0%) on 03-jun-2010 [ 1 2 ] using (pfizer, new_york)
• nueva_york (city)
• OE @883 (100.0%) on 30-oct-2014 [ http://www.businesswire.com/news/home/20110125006020/en/Pfizer-Announces-York-City%E2%80%99s-Top-Research-Hospitals http://www.businesswire.com/news/home/20110125006020/en/Pfizer-Announces-York-City%E2%80%99s-Top-Research-Hospitals http://www.pfizer.com/news/press-release/press-release-archive-detail/pfizer_announces_seven_of_new_york_city_s_top_research_hospitals_join_global_centers_for_therapeutic_innovation http://www.businesswire.com/news/home/20110125006020/en/Pfizer-Announces-York-City%E2%80%99s-Top-Research-Hospitals http://en.wikipedia.org/wiki/Pfizer http://www.businesswire.com/news/home/20110125006020/en/Pfizer-Announces-York-City%E2%80%99s-Top-Research-Hospitals  ] using (pfizer, new_york_city)
• Human feedback from bkisiel @840 on 23-may-2014 [ "pfizer headquarteredin new_york_city", Action=(+headquarteredin) (from NELL.08m.840.SSFeedback.csv) ] using (pfizer, new_york_city)
• CPL @1104 (87.5%) on 18-mar-2018 [ "arg1 Pharmaceuticals in arg2" "arg1 world headquarters in arg2" "arg1 Finance Manager Salaries in arg2" ] using (pfizer, new_york_city)
• SEAL @580 (50.0%) on 27-may-2012 [ 1 ] using (pfizer, new_york_city)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:agentinteractswithagent,concept:agentinteractswithagent,concept:organizationheadquarteredincity" "Y~X0~concept:agentinteractswithagent,concept:agentinteractswithagent,concept:hasofficeincity" "Y~X0~concept:agentinteractswithagent,concept:agentinteractswithagent,concept:agentactsinlocation" "Y~X0~concept:agentinteractswithagent,concept:agentinteractswithagent,concept:organizationactsinlocation" "Y~X0~concept:agentinteractswithagent,concept:agentinteractswithagent,concept:agentrelatedtolocation" ] using (pfizer, new_york_city)
• sandwich (city)
• CPL @1096 (87.5%) on 18-jan-2018 [ "arg1 Laboratories in arg2" "arg1 Global Research and Development in arg2" "arg1 Central Research in arg2" ] using (pfizer, sandwich)
• san_diego (city)
• CPL @1100 (50.0%) on 31-jan-2018 [ "arg1 Pharmaceuticals in arg2" ] using (pfizer, san_diego)
• surrey (city)
• CPL @1105 (50.0%) on 25-mar-2018 [ "arg1 Consumer Healthcare in arg2" ] using (pfizer, surrey)
• uk (city)
• CPL @1104 (75.0%) on 18-mar-2018 [ "arg1 Pharmaceuticals in arg2" "arg1 Central Research in arg2" ] using (pfizer, uk)
• mutualproxyfor
• years (militaryconflict)
• CPL @1112 (50.0%) on 20-jul-2018 [ "arg1 Mexico for four arg2" ] using (pfizer, years)
• CPL @1112 (50.0%) on 20-jul-2018 [ "arg1 Mexico for four arg2" ] using (years, pfizer)
• years (musicalbum)
• CPL @1112 (50.0%) on 20-jul-2018 [ "arg1 Mexico for four arg2" ] using (pfizer, years)
• CPL @1112 (50.0%) on 20-jul-2018 [ "arg1 Mexico for four arg2" ] using (years, pfizer)
• years (sportsgame)
• CPL @1112 (50.0%) on 20-jul-2018 [ "arg1 Mexico for four arg2" ] using (pfizer, years)
• CPL @1112 (50.0%) on 20-jul-2018 [ "arg1 Mexico for four arg2" ] using (years, pfizer)
• organizationalsoknownas
• sony (biotechcompany)
• CPL @1094 (50.0%) on 01-jan-2018 [ "arg1 Music Entertainment and arg2" ] using (pfizer, sony)
• CPL @1094 (50.0%) on 01-jan-2018 [ "arg1 Music Entertainment and arg2" ] using (sony, pfizer)
• sony (recordlabel)
• CPL @1094 (50.0%) on 01-jan-2018 [ "arg1 Music Entertainment and arg2" ] using (pfizer, sony)
• CPL @1094 (50.0%) on 01-jan-2018 [ "arg1 Music Entertainment and arg2" ] using (sony, pfizer)
• organizationheadquarteredincity
• center (city)
• CPL @1104 (50.0%) on 18-mar-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• nueva_york (city)
• CPL @1104 (50.0%) on 18-mar-2018 [ "arg1 world headquarters in arg2" ] using (pfizer, new_york_city)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:hasofficeincity" "Y~X0~concept:agentinteractswithagent,concept:agentinteractswithagent,concept:organizationactsinlocation" "Y~_z-concept:country:usa~concept:geopoliticallocationcontainsstate,concept:statecontainscity" "Y~X0~concept:hasofficeincity,concept:cityhasairport,concept:atlocation" "Y~_z-concept:country:countries~concept:generalizationof,concept:countrycities" ] using (pfizer, new_york_city)
• OE @1021 (89.3%) on 14-oct-2016 [ http://www.businesswire.com/news/home/20110125006020/en/Pfizer-Announces-York-City%E2%80%99s-Top-Research-Hospitals http://www.businesswire.com/news/home/20110125006020/en/Pfizer-Announces-York-City%E2%80%99s-Top-Research-Hospitals http://www.businesswire.com/news/home/20110125006020/en/Pfizer-Announces-York-City%E2%80%99s-Top-Research-Hospitals http://en.wikipedia.org/wiki/Pfizer http://www.businesswire.com/news/home/20110125006020/en/Pfizer-Announces-York-City%E2%80%99s-Top-Research-Hospitals  ] using (pfizer, new_york_city)
• sandwich (city)
• CPL @1104 (75.0%) on 18-mar-2018 [ "arg1 Global Research and Development in arg2" "arg1 Central Research in arg2" ] using (pfizer, sandwich)
• uk (city)
• CPL @1104 (50.0%) on 18-mar-2018 [ "arg1 Central Research in arg2" ] using (pfizer, uk)
• acquired
• biorexis
• CPL @1103 (75.0%) on 06-mar-2018 [ "arg1 recently bought out arg2" "arg1 acquired arg2" ] using (pfizer, biorexis)
• covx
• CPL @1095 (87.5%) on 17-jan-2018 [ "arg1 has acquired arg2" "arg1 has agreed to acquire arg2" "arg1 subsidiary arg2" ] using (pfizer, covx)
• esperion
• CPL @1105 (75.0%) on 25-mar-2018 [ "arg2 prior to its acquisition by arg1" "arg2 was acquired by arg1" ] using (pfizer, esperion)
• esperion001
• CPL @1105 (75.0%) on 25-mar-2018 [ "arg2 prior to its acquisition by arg1" "arg2 was acquired by arg1" ] using (pfizer, esperion)
• esperion002
• CPL @1105 (75.0%) on 25-mar-2018 [ "arg2 prior to its acquisition by arg1" "arg2 was acquired by arg1" ] using (pfizer, esperion)
• esperion003
• CPL @1105 (75.0%) on 25-mar-2018 [ "arg2 prior to its acquisition by arg1" "arg2 was acquired by arg1" ] using (pfizer, esperion)
• esperion004
• CPL @1105 (75.0%) on 25-mar-2018 [ "arg2 prior to its acquisition by arg1" "arg2 was acquired by arg1" ] using (pfizer, esperion)
• esperion005
• CPL @1105 (75.0%) on 25-mar-2018 [ "arg2 prior to its acquisition by arg1" "arg2 was acquired by arg1" ] using (pfizer, esperion)
• esperion006
• CPL @1105 (75.0%) on 25-mar-2018 [ "arg2 prior to its acquisition by arg1" "arg2 was acquired by arg1" ] using (pfizer, esperion)
• esperion007
• CPL @1105 (75.0%) on 25-mar-2018 [ "arg2 prior to its acquisition by arg1" "arg2 was acquired by arg1" ] using (pfizer, esperion)
• quigley
• CPL @1100 (75.0%) on 31-jan-2018 [ "arg1 acquired arg2" "arg1 bought arg2" ] using (pfizer, quigley)
• rival_wyeth
• CPL @1098 (75.0%) on 21-jan-2018 [ "arg1 in talks to buy arg2" "arg1 acquired arg2" ] using (pfizer, rival_wyeth)
• wyeth (blog)
• OE @841 (89.7%) on 25-may-2014 [ http://www.sec.gov/News/PressRelease/Detail/PressRelease/1365171483696 http://www.wikinvest.com/stock/Pfizer_(PFE)/Wyeth_(WYE) http://www.wikinvest.com/stock/Pfizer_(PFE)/Wyeth_(WYE) http://en.wikipedia.org/wiki/Wyeth http://www.wikinvest.com/stock/Pfizer_(PFE)/Wyeth_(WYE) http://online.wsj.com/news/articles/SB123293456420414421 http://www.sec.gov/News/PressRelease/Detail/PressRelease/1365171483696 http://www.sec.gov/News/PressRelease/Detail/PressRelease/1365171483696 http://money.cnn.com/2009/01/26/news/companies/pfizer_wyeth/ http://money.cnn.com/2009/01/26/news/companies/pfizer_wyeth/ http://www.fiercebiotech.com/story/pfizers-megamerger-pitch-haunted-empty-promises-past/2014-05-08 http://www.businessweek.com/bwdaily/dnflash/content/jan2009/db20090126_540552.htm http://en.wikipedia.org/wiki/Wyeth http://www.pfizer.com/news/press-release/press-release-archive-detail/pfizer_subsidiary_wyeth_llc_to_redeem_5_500_notes_due_february_1_2014 http://www.businessweek.com/bwdaily/dnflash/content/jan2009/db20090126_540552.htm http://articles.economictimes.indiatimes.com/2013-11-27/news/44520986_1_pfizer-wyeth-pfizer-and-wyeth-wyeth-stock http://www.youtube.com/watch?v=32n0WQ_YX9A http://www.sec.gov/News/PressRelease/Detail/PressRelease/1365171483696 http://www.businessweek.com/bwdaily/dnflash/content/jan2009/db20090126_540552.htm  ] using (pfizer, wyeth)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:worker,concept:personbelongstoorganization,concept:superpartoforganization" "Y~_X0~concept:organizationleadbyagent,concept:personbelongstoorganization,concept:superpartof" "Y~_X0~concept:organizationleadbyagent,concept:worksfor,concept:superpartof" "Y~_X0~concept:organizationleadbyagent,concept:personbelongstoorganization,concept:agentcontrols" "Y~_X0~concept:proxyof,concept:personbelongstoorganization,concept:superpartof" ] using (pfizer, wyeth)
• CPL @1094 (100.0%) on 01-jan-2018 [ "arg1 finalized its acquisition of arg2" "arg1 and its subsidiary arg2" "arg1 bought out arg2" "arg1 is about to buy arg2" "arg1 when it acquired arg2" "arg1 agrees to buy arg2" "arg1 to Acquire arg2" "arg1 plans to merge with arg2" "arg1 recently acquired arg2" "arg1 is in talks to buy arg2" "arg1 announced that it was acquiring arg2" "arg1 when that company acquired arg2" "arg1 is acquiring arg2" "arg1 acquired arg2" "arg1 following its purchase of arg2" "arg1 has since acquired arg2" "arg1 DDDD acquisition of arg2" "arg1 has acquired arg2" "arg1 has agreed to buy arg2" "arg1 announced the acquisition of arg2" "arg1 agreed to acquire arg2" "arg1 is about to acquire arg2" "arg1 in Talks to Buy arg2" "arg1 in talks to buy arg2" "arg1 Takeover of arg2" "arg1 announced plans to acquire arg2" "arg1 Agrees to Acquire arg2" "arg1 recently bought arg2" "arg1 bought arg2" "arg1 agreed to buy arg2" "arg1 in its acquisition of arg2" ] using (pfizer, wyeth)
• warner (company)
• CPL @1096 (75.0%) on 18-jan-2018 [ "arg2 merged with arg1" "arg2 was acquired by arg1" ] using (pfizer, warner)
• wyeth (company)
• OE @841 (89.7%) on 25-may-2014 [ http://www.sec.gov/News/PressRelease/Detail/PressRelease/1365171483696 http://www.wikinvest.com/stock/Pfizer_(PFE)/Wyeth_(WYE) http://www.wikinvest.com/stock/Pfizer_(PFE)/Wyeth_(WYE) http://en.wikipedia.org/wiki/Wyeth http://www.wikinvest.com/stock/Pfizer_(PFE)/Wyeth_(WYE) http://online.wsj.com/news/articles/SB123293456420414421 http://www.sec.gov/News/PressRelease/Detail/PressRelease/1365171483696 http://www.sec.gov/News/PressRelease/Detail/PressRelease/1365171483696 http://money.cnn.com/2009/01/26/news/companies/pfizer_wyeth/ http://money.cnn.com/2009/01/26/news/companies/pfizer_wyeth/ http://www.fiercebiotech.com/story/pfizers-megamerger-pitch-haunted-empty-promises-past/2014-05-08 http://www.businessweek.com/bwdaily/dnflash/content/jan2009/db20090126_540552.htm http://en.wikipedia.org/wiki/Wyeth http://www.pfizer.com/news/press-release/press-release-archive-detail/pfizer_subsidiary_wyeth_llc_to_redeem_5_500_notes_due_february_1_2014 http://www.businessweek.com/bwdaily/dnflash/content/jan2009/db20090126_540552.htm http://articles.economictimes.indiatimes.com/2013-11-27/news/44520986_1_pfizer-wyeth-pfizer-and-wyeth-wyeth-stock http://www.youtube.com/watch?v=32n0WQ_YX9A http://www.sec.gov/News/PressRelease/Detail/PressRelease/1365171483696 http://www.businessweek.com/bwdaily/dnflash/content/jan2009/db20090126_540552.htm  ] using (pfizer, wyeth)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:worker,concept:personbelongstoorganization,concept:superpartoforganization" "Y~_X0~concept:organizationleadbyagent,concept:personbelongstoorganization,concept:superpartof" "Y~_X0~concept:organizationleadbyagent,concept:worksfor,concept:superpartof" "Y~_X0~concept:organizationleadbyagent,concept:personbelongstoorganization,concept:agentcontrols" "Y~_X0~concept:proxyof,concept:personbelongstoorganization,concept:superpartof" ] using (pfizer, wyeth)
• CPL @1094 (100.0%) on 01-jan-2018 [ "arg1 finalized its acquisition of arg2" "arg1 and its subsidiary arg2" "arg1 bought out arg2" "arg1 is about to buy arg2" "arg1 when it acquired arg2" "arg1 agrees to buy arg2" "arg1 to Acquire arg2" "arg1 plans to merge with arg2" "arg1 recently acquired arg2" "arg1 is in talks to buy arg2" "arg1 announced that it was acquiring arg2" "arg1 when that company acquired arg2" "arg1 is acquiring arg2" "arg1 acquired arg2" "arg1 following its purchase of arg2" "arg1 has since acquired arg2" "arg1 DDDD acquisition of arg2" "arg1 has acquired arg2" "arg1 has agreed to buy arg2" "arg1 announced the acquisition of arg2" "arg1 agreed to acquire arg2" "arg1 is about to acquire arg2" "arg1 in Talks to Buy arg2" "arg1 in talks to buy arg2" "arg1 Takeover of arg2" "arg1 announced plans to acquire arg2" "arg1 Agrees to Acquire arg2" "arg1 recently bought arg2" "arg1 bought arg2" "arg1 agreed to buy arg2" "arg1 in its acquisition of arg2" ] using (pfizer, wyeth)
• king (country)
• CPL @1100 (75.0%) on 31-jan-2018 [ "arg2 was acquired by arg1" "arg2 was later acquired by arg1" ] using (pfizer, king)
• bextra (drug)
• CPL @1099 (50.0%) on 23-jan-2018 [ "arg1 acquired arg2" ] using (pfizer, bextra)
• neurontin
• CPL @1097 (75.0%) on 19-jan-2018 [ "arg2 is now owned by arg1" "arg2 was acquired by arg1" ] using (pfizer, neurontin)
• prempro (drug)
• CPL @1107 (50.0%) on 24-may-2018 [ "arg1 recently acquired arg2" ] using (pfizer, prempro)
• wyeth (drug)
• OE @841 (89.7%) on 25-may-2014 [ http://www.sec.gov/News/PressRelease/Detail/PressRelease/1365171483696 http://www.wikinvest.com/stock/Pfizer_(PFE)/Wyeth_(WYE) http://www.wikinvest.com/stock/Pfizer_(PFE)/Wyeth_(WYE) http://en.wikipedia.org/wiki/Wyeth http://www.wikinvest.com/stock/Pfizer_(PFE)/Wyeth_(WYE) http://online.wsj.com/news/articles/SB123293456420414421 http://www.sec.gov/News/PressRelease/Detail/PressRelease/1365171483696 http://www.sec.gov/News/PressRelease/Detail/PressRelease/1365171483696 http://money.cnn.com/2009/01/26/news/companies/pfizer_wyeth/ http://money.cnn.com/2009/01/26/news/companies/pfizer_wyeth/ http://www.fiercebiotech.com/story/pfizers-megamerger-pitch-haunted-empty-promises-past/2014-05-08 http://www.businessweek.com/bwdaily/dnflash/content/jan2009/db20090126_540552.htm http://en.wikipedia.org/wiki/Wyeth http://www.pfizer.com/news/press-release/press-release-archive-detail/pfizer_subsidiary_wyeth_llc_to_redeem_5_500_notes_due_february_1_2014 http://www.businessweek.com/bwdaily/dnflash/content/jan2009/db20090126_540552.htm http://articles.economictimes.indiatimes.com/2013-11-27/news/44520986_1_pfizer-wyeth-pfizer-and-wyeth-wyeth-stock http://www.youtube.com/watch?v=32n0WQ_YX9A http://www.sec.gov/News/PressRelease/Detail/PressRelease/1365171483696 http://www.businessweek.com/bwdaily/dnflash/content/jan2009/db20090126_540552.htm  ] using (pfizer, wyeth)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:worker,concept:personbelongstoorganization,concept:superpartoforganization" "Y~_X0~concept:organizationleadbyagent,concept:personbelongstoorganization,concept:superpartof" "Y~_X0~concept:organizationleadbyagent,concept:worksfor,concept:superpartof" "Y~_X0~concept:organizationleadbyagent,concept:personbelongstoorganization,concept:agentcontrols" "Y~_X0~concept:proxyof,concept:personbelongstoorganization,concept:superpartof" ] using (pfizer, wyeth)
• CPL @1094 (100.0%) on 01-jan-2018 [ "arg1 finalized its acquisition of arg2" "arg1 and its subsidiary arg2" "arg1 bought out arg2" "arg1 is about to buy arg2" "arg1 when it acquired arg2" "arg1 agrees to buy arg2" "arg1 to Acquire arg2" "arg1 plans to merge with arg2" "arg1 recently acquired arg2" "arg1 is in talks to buy arg2" "arg1 announced that it was acquiring arg2" "arg1 when that company acquired arg2" "arg1 is acquiring arg2" "arg1 acquired arg2" "arg1 following its purchase of arg2" "arg1 has since acquired arg2" "arg1 DDDD acquisition of arg2" "arg1 has acquired arg2" "arg1 has agreed to buy arg2" "arg1 announced the acquisition of arg2" "arg1 agreed to acquire arg2" "arg1 is about to acquire arg2" "arg1 in Talks to Buy arg2" "arg1 in talks to buy arg2" "arg1 Takeover of arg2" "arg1 announced plans to acquire arg2" "arg1 Agrees to Acquire arg2" "arg1 recently bought arg2" "arg1 bought arg2" "arg1 agreed to buy arg2" "arg1 in its acquisition of arg2" ] using (pfizer, wyeth)
• coley
• CPL @1097 (75.0%) on 19-jan-2018 [ "arg1 announced it would buy arg2" "arg1 completed the acquisition of arg2" ] using (pfizer, coley)
• king (jobposition)
• CPL @1100 (75.0%) on 31-jan-2018 [ "arg2 was acquired by arg1" "arg2 was later acquired by arg1" ] using (pfizer, king)
• king (musicalbum)
• CPL @1100 (75.0%) on 31-jan-2018 [ "arg2 was acquired by arg1" "arg2 was later acquired by arg1" ] using (pfizer, king)
• king (musicartist)
• CPL @1100 (75.0%) on 31-jan-2018 [ "arg2 was acquired by arg1" "arg2 was later acquired by arg1" ] using (pfizer, king)
• king (person)
• CPL @1100 (75.0%) on 31-jan-2018 [ "arg2 was acquired by arg1" "arg2 was later acquired by arg1" ] using (pfizer, king)
• warner (personafrica)
• CPL @1096 (75.0%) on 18-jan-2018 [ "arg2 merged with arg1" "arg2 was acquired by arg1" ] using (pfizer, warner)
• warner (politicianus)
• CPL @1096 (75.0%) on 18-jan-2018 [ "arg2 merged with arg1" "arg2 was acquired by arg1" ] using (pfizer, warner)
• king (port)
• CPL @1100 (75.0%) on 31-jan-2018 [ "arg2 was acquired by arg1" "arg2 was later acquired by arg1" ] using (pfizer, king)
• king_pharmaceuticals (professionalorganization)
• CPL @1094 (87.5%) on 01-jan-2018 [ "arg1 is acquiring arg2" "arg1 bought arg2" "arg1 completed its acquisition of arg2" ] using (pfizer, king_pharmaceuticals)
• king (sociopolitical)
• CPL @1100 (75.0%) on 31-jan-2018 [ "arg2 was acquired by arg1" "arg2 was later acquired by arg1" ] using (pfizer, king)
• bextra (videogame)
• CPL @1099 (50.0%) on 23-jan-2018 [ "arg1 acquired arg2" ] using (pfizer, bextra)
• prempro (videogame)
• CPL @1107 (50.0%) on 24-may-2018 [ "arg1 recently acquired arg2" ] using (pfizer, prempro)
• upjohn (visualartist)
• CPL @1096 (50.0%) on 18-jan-2018 [ "arg1 bought arg2" ] using (pfizer, upjohn)
• king_tv
• CPL @1100 (75.0%) on 31-jan-2018 [ "arg2 was acquired by arg1" "arg2 was later acquired by arg1" ] using (pfizer, king)
• agentcompeteswithagent
• roche (winery)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agenthierarchicallyaboveagent,concept:agentcontrols,concept:agentcompeteswithagent" "Y~_X0~concept:agentcontrols,concept:agentcontrols,concept:agentcompeteswithagent" "Y~_X0~concept:superpartof,concept:agentcontrols,concept:agentcompeteswithagent" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcollaborateswithagent,concept:agentcompeteswithagent" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcontrols,concept:agentcompeteswithagent" ] using (roche, pfizer)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agenthierarchicallyaboveagent,concept:agentcontrols,concept:agentcompeteswithagent" "Y~_X0~concept:agentcontrols,concept:agentcontrols,concept:agentcompeteswithagent" "Y~_X0~concept:superpartof,concept:agentcontrols,concept:agentcompeteswithagent" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcollaborateswithagent,concept:agentcompeteswithagent" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcontrols,concept:agentcompeteswithagent" ] using (pfizer, roche)
• OE @962 (100.0%) on 05-dec-2015 [ http://www.pharmatelevision.com/Video/247-Panel-Discussion-Panel-discussion--David-Rosen-Pfizer-Robert-Silverman-Roche-Jonathan-Montagu-CoNCERT-Pharmaceuticals.aspx http://www.pharmatelevision.com/Video/254-Panel-Discussion-Panel-discussion--David-Rosen-Pfizer-Robert-Silverman-Roche-Jonathan-Montagu-CoNCERT-Pharmaceuticals.aspx http://www.fiercepharma.com/story/pfizer-roche-gsk-said-be-knocking-heads-generics-eu-drug-tracking/2012-04-27 http://www.pharmatelevision.com/Video/247-Panel-Discussion-Panel-discussion--David-Rosen-Pfizer-Robert-Silverman-Roche-Jonathan-Montagu-CoNCERT-Pharmaceuticals.aspx http://www.pharmatelevision.com/Video/247-Panel-Discussion-Panel-discussion--David-Rosen-Pfizer-Robert-Silverman-Roche-Jonathan-Montagu-CoNCERT-Pharmaceuticals.aspx http://www.pharmatelevision.com/Video/254-Panel-Discussion-Panel-discussion--David-Rosen-Pfizer-Robert-Silverman-Roche-Jonathan-Montagu-CoNCERT-Pharmaceuticals.aspx http://www.pharmatelevision.com/Video/247-Panel-Discussion-Panel-discussion--David-Rosen-Pfizer-Robert-Silverman-Roche-Jonathan-Montagu-CoNCERT-Pharmaceuticals.aspx http://www.pharmatelevision.com/Video/254-Panel-Discussion-Panel-discussion--David-Rosen-Pfizer-Robert-Silverman-Roche-Jonathan-Montagu-CoNCERT-Pharmaceuticals.aspx http://www.forbes.com/sites/matthewherper/2012/05/07/failure-of-roche-hdl-booster-is-bad-news-for-merck-and-eli-lilly/ http://www.bloomberg.com/news/2011-08-19/roche-seeks-6-8-billion-win-on-heart-pill-where-pfizer-failed.html http://www.pharmatelevision.com/Video/247-Panel-Discussion-Panel-discussion--David-Rosen-Pfizer-Robert-Silverman-Roche-Jonathan-Montagu-CoNCERT-Pharmaceuticals.aspx  ] using (roche, pfizer)
• OE @962 (100.0%) on 05-dec-2015 [ http://www.pharmatelevision.com/Video/247-Panel-Discussion-Panel-discussion--David-Rosen-Pfizer-Robert-Silverman-Roche-Jonathan-Montagu-CoNCERT-Pharmaceuticals.aspx http://www.pharmatelevision.com/Video/254-Panel-Discussion-Panel-discussion--David-Rosen-Pfizer-Robert-Silverman-Roche-Jonathan-Montagu-CoNCERT-Pharmaceuticals.aspx http://www.fiercepharma.com/story/pfizer-roche-gsk-said-be-knocking-heads-generics-eu-drug-tracking/2012-04-27 http://www.pharmatelevision.com/Video/247-Panel-Discussion-Panel-discussion--David-Rosen-Pfizer-Robert-Silverman-Roche-Jonathan-Montagu-CoNCERT-Pharmaceuticals.aspx http://www.pharmatelevision.com/Video/247-Panel-Discussion-Panel-discussion--David-Rosen-Pfizer-Robert-Silverman-Roche-Jonathan-Montagu-CoNCERT-Pharmaceuticals.aspx http://www.pharmatelevision.com/Video/254-Panel-Discussion-Panel-discussion--David-Rosen-Pfizer-Robert-Silverman-Roche-Jonathan-Montagu-CoNCERT-Pharmaceuticals.aspx http://www.pharmatelevision.com/Video/247-Panel-Discussion-Panel-discussion--David-Rosen-Pfizer-Robert-Silverman-Roche-Jonathan-Montagu-CoNCERT-Pharmaceuticals.aspx http://www.pharmatelevision.com/Video/254-Panel-Discussion-Panel-discussion--David-Rosen-Pfizer-Robert-Silverman-Roche-Jonathan-Montagu-CoNCERT-Pharmaceuticals.aspx http://www.forbes.com/sites/matthewherper/2012/05/07/failure-of-roche-hdl-booster-is-bad-news-for-merck-and-eli-lilly/ http://www.bloomberg.com/news/2011-08-19/roche-seeks-6-8-billion-win-on-heart-pill-where-pfizer-failed.html http://www.pharmatelevision.com/Video/247-Panel-Discussion-Panel-discussion--David-Rosen-Pfizer-Robert-Silverman-Roche-Jonathan-Montagu-CoNCERT-Pharmaceuticals.aspx  ] using (pfizer, roche)
• agentcontrols
• wyeth (blog)
• CPL @1095 (87.5%) on 17-jan-2018 [ "arg1 to Acquire arg2" "arg1 in Talks to Buy arg2" "arg1 announced plans to acquire arg2" ] using (pfizer, wyeth)
• wyeth (company)
• CPL @1095 (87.5%) on 17-jan-2018 [ "arg1 to Acquire arg2" "arg1 in Talks to Buy arg2" "arg1 announced plans to acquire arg2" ] using (pfizer, wyeth)
• wyeth (drug)
• CPL @1095 (87.5%) on 17-jan-2018 [ "arg1 to Acquire arg2" "arg1 in Talks to Buy arg2" "arg1 announced plans to acquire arg2" ] using (pfizer, wyeth)
• agentinvolvedwithitem
• sunitinib (archaea)
• CPL @1112 (50.0%) on 20-jul-2018 [ "arg1 cut the price of arg2" ] using (pfizer, sunitinib)
• information (attraction)
• CPL @1107 (50.0%) on 24-may-2018 [ "arg1 will unveil new arg2" ] using (pfizer, information)
• information (boardgame)
• CPL @1107 (50.0%) on 24-may-2018 [ "arg1 will unveil new arg2" ] using (pfizer, information)
• information (braintissue)
• CPL @1107 (50.0%) on 24-may-2018 [ "arg1 will unveil new arg2" ] using (pfizer, information)
• information (buildingfeature)
• CPL @1107 (50.0%) on 24-may-2018 [ "arg1 will unveil new arg2" ] using (pfizer, information)
• information (buildingmaterial)
• CPL @1107 (50.0%) on 24-may-2018 [ "arg1 will unveil new arg2" ] using (pfizer, information)
• information (chemical)
• CPL @1107 (50.0%) on 24-may-2018 [ "arg1 will unveil new arg2" ] using (pfizer, information)
• lipitor (chemical)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentcreated" "Y~X0~concept:agentcreated" "Y~X0~concept:agentcreated,concept:producedby,concept:agentcreated" "Y~X0~concept:agentcreated,concept:iteminvolvedwithagent,concept:agentcreated" "Y~_X0~concept:agentcreated,concept:producedby,concept:producesproduct" ] using (pfizer, lipitor)
• CPL @1107 (50.0%) on 24-may-2018 [ "arg1 under the trade name arg2" ] using (pfizer, lipitor)
• OE @970 (100.0%) on 09-jan-2016 [ http://www.medicalnewstoday.com/articles/238542.php http://www.webmd.com/cholesterol-management/news/20111129/faq-generic-lipitor http://www.medicalnewstoday.com/articles/238542.php http://www.huffingtonpost.com/2011/11/29/lipitor-generic-pfizer_n_1119364.html http://online.wsj.com/article/SB10001424052702304550004577510613860845578.html http://online.wsj.com/article/SB10001424052702304550004577510613860845578.html http://en.wikipedia.org/wiki/Pfizer http://www.news-medical.net/health/Lipitor-What-is-Lipitor-(Spanish).aspx http://www.pubpat.org/pfizerlipitor.htm http://www.huffingtonpost.com/2011/11/29/lipitor-generic-pfizer_n_1119364.html http://www.news-medical.net/health/Lipitor-What-is-Lipitor.aspx http://www.huffingtonpost.com/2011/11/29/lipitor-generic-pfizer_n_1119364.html http://en.wikipedia.org/wiki/Pfizer http://www.webmd.com/cholesterol-management/news/20111129/faq-generic-lipitor http://www.news-medical.net/health/Lipitor-What-is-Lipitor-(Spanish).aspx http://www.news-medical.net/health/Lipitor-What-is-Lipitor.aspx http://articles.latimes.com/2012/jan/16/health/la-he-lipitor-generic-20120116 http://articles.latimes.com/2012/jan/16/health/la-he-lipitor-generic-20120116 http://www.webmd.com/cholesterol-management/news/20111129/faq-generic-lipitor http://www.medicalnewstoday.com/articles/238542.php  ] using (pfizer, lipitor)
• information (company)
• CPL @1107 (50.0%) on 24-may-2018 [ "arg1 will unveil new arg2" ] using (pfizer, information)
• information (convention)
• CPL @1107 (50.0%) on 24-may-2018 [ "arg1 will unveil new arg2" ] using (pfizer, information)
• information (disease)
• CPL @1107 (50.0%) on 24-may-2018 [ "arg1 will unveil new arg2" ] using (pfizer, information)
• information (eventoutcome)
• CPL @1107 (50.0%) on 24-may-2018 [ "arg1 will unveil new arg2" ] using (pfizer, information)
• information (furniture)
• CPL @1107 (50.0%) on 24-may-2018 [ "arg1 will unveil new arg2" ] using (pfizer, information)
• information (kitchenitem)
• CPL @1107 (50.0%) on 24-may-2018 [ "arg1 will unveil new arg2" ] using (pfizer, information)
• information (mediatype)
• CPL @1107 (50.0%) on 24-may-2018 [ "arg1 will unveil new arg2" ] using (pfizer, information)
• information (mlalgorithm)
• CPL @1107 (50.0%) on 24-may-2018 [ "arg1 will unveil new arg2" ] using (pfizer, information)
• information (musicalbum)
• CPL @1107 (50.0%) on 24-may-2018 [ "arg1 will unveil new arg2" ] using (pfizer, information)
• information (nerve)
• CPL @1107 (50.0%) on 24-may-2018 [ "arg1 will unveil new arg2" ] using (pfizer, information)
• information (nongovorganization)
• CPL @1107 (50.0%) on 24-may-2018 [ "arg1 will unveil new arg2" ] using (pfizer, information)
• information (plant)
• CPL @1107 (50.0%) on 24-may-2018 [ "arg1 will unveil new arg2" ] using (pfizer, information)
• information (politicsissue)
• CPL @1107 (50.0%) on 24-may-2018 [ "arg1 will unveil new arg2" ] using (pfizer, information)
• information (profession)
• CPL @1107 (50.0%) on 24-may-2018 [ "arg1 will unveil new arg2" ] using (pfizer, information)
• information (reptile)
• CPL @1107 (50.0%) on 24-may-2018 [ "arg1 will unveil new arg2" ] using (pfizer, information)
• information (scientificterm)
• CPL @1107 (50.0%) on 24-may-2018 [ "arg1 will unveil new arg2" ] using (pfizer, information)
• information (tool)
• CPL @1107 (50.0%) on 24-may-2018 [ "arg1 will unveil new arg2" ] using (pfizer, information)
• bextra (videogame)
• CPL @1104 (75.0%) on 18-mar-2018 [ "arg1 voluntarily pulled arg2" "arg1 to voluntarily remove arg2" ] using (pfizer, bextra)
• information (visualartmovement)
• CPL @1107 (50.0%) on 24-may-2018 [ "arg1 will unveil new arg2" ] using (pfizer, information)
• information (visualizablescene)
• CPL @1107 (50.0%) on 24-may-2018 [ "arg1 will unveil new arg2" ] using (pfizer, information)
• companyeconomicsector
• industry (academicfield)
• CPL @1097 (93.8%) on 19-jan-2018 [ "arg2 giant such as arg1" "arg2 companies such as arg1" "arg2 partners include arg1" "arg2 giants including arg1" ] using (pfizer, industry)
• pharmacy (academicfield)
• CPL @1099 (87.5%) on 23-jan-2018 [ "arg2 companies such as arg1" "arg2 company named arg1" "arg2 companies like arg1" ] using (pfizer, pharmacy)
• industry (animal)
• CPL @1097 (93.8%) on 19-jan-2018 [ "arg2 giant such as arg1" "arg2 companies such as arg1" "arg2 partners include arg1" "arg2 giants including arg1" ] using (pfizer, industry)
• industry (bathroomitem)
• CPL @1097 (93.8%) on 19-jan-2018 [ "arg2 giant such as arg1" "arg2 companies such as arg1" "arg2 partners include arg1" "arg2 giants including arg1" ] using (pfizer, industry)
• pharma
• OE @836 (90.8%) on 09-may-2014 [ http://www.xconomy.com/new-york/2012/10/30/tris-pharma-benefits-from-pfizernextwave-deal/ http://www.fool.com/investing/general/2014/01/25/pfizer-inc-earnings-can-the-big-pharma-stock-keep.aspx http://en.wikipedia.org/wiki/Pfizer http://en.wikipedia.org/wiki/Pfizer http://www.irishtimes.com/business/sectors/health-pharma/pharma-stocks-soar-on-back-of-pfizer-s-move-for-astrazeneca-1.1776317 http://www.smh.com.au/business/world-business/pfizer-confirms-offer-to-astrazeneca-for-megapharma-merger-20140428-37dui.html http://www.fiercepharma.com/tags/pfizer http://en.wikipedia.org/wiki/Pfizer http://en.wikipedia.org/wiki/Pfizer http://www.theguardian.com/commentisfree/2014/may/07/pfizer-astrazeneca-big-pharma http://www.bloomberg.com/news/2014-04-22/pfizer-astrazeneca-are-ripe-for-pharma-deal-real-m-a.html http://www.fool.com/investing/general/2014/01/25/pfizer-inc-earnings-can-the-big-pharma-stock-keep.aspx http://wallstcheatsheet.com/business/pharma-drama-pfizer-fails-to-woo-astrazeneca-valeant-pursues-allergan.html/?a=viewall http://en.wikipedia.org/wiki/Pfizer http://en.wikipedia.org/wiki/Pfizer http://www.thefinaledition.com/article/from-pharma-to-table-the-mcdonalds-pfizer-merger.html  ] using (pfizer, pharma)
• industry (charactertrait)
• CPL @1097 (93.8%) on 19-jan-2018 [ "arg2 giant such as arg1" "arg2 companies such as arg1" "arg2 partners include arg1" "arg2 giants including arg1" ] using (pfizer, industry)
• medical_device
• CPL @1099 (87.5%) on 23-jan-2018 [ "arg2 manufacturers such as arg1" "arg2 companies like arg1" "arg2 companies such as arg1" ] using (pfizer, medical_device)
• pharmaceutical (drug)
• OE @896 (99.7%) on 23-jan-2015 [ http://www.bloomberg.com/quote/PFE:US http://en.wikipedia.org/wiki/Pfizer http://en.wikipedia.org/wiki/Pfizer http://en.wikipedia.org/wiki/Pfizer http://en.wikipedia.org/wiki/Pfizer http://en.wikipedia.org/wiki/Pfizer  ] using (pfizer, pharmaceutical)
• CPL @1095 (96.9%) on 17-jan-2018 [ "arg2 company like arg1" "arg2 companies like arg1" "arg2 companies including arg1" "arg2 companies such as arg1" "arg2 manufacturers such as arg1" ] using (pfizer, pharmaceutical)
• pharmacy (drug)
• CPL @1099 (87.5%) on 23-jan-2018 [ "arg2 companies such as arg1" "arg2 company named arg1" "arg2 companies like arg1" ] using (pfizer, pharmacy)
• major_drug
• CPL @1098 (87.5%) on 21-jan-2018 [ "arg2 company like arg1" "arg2 companies like arg1" "arg2 companies such as arg1" ] using (pfizer, major_drug)
• industry (governmentorganization)
• CPL @1097 (93.8%) on 19-jan-2018 [ "arg2 giant such as arg1" "arg2 companies such as arg1" "arg2 partners include arg1" "arg2 giants including arg1" ] using (pfizer, industry)
• n100 (mldataset)
• CPL @1100 (75.0%) on 31-jan-2018 [ "arg2 companies including arg1" "arg2 companies like arg1" ] using (pfizer, n100)
• innovator
• CPL @1099 (75.0%) on 23-jan-2018 [ "arg2 company like arg1" "arg2 companies such as arg1" ] using (pfizer, innovator)
• n100 (nonneginteger)
• CPL @1100 (75.0%) on 31-jan-2018 [ "arg2 companies including arg1" "arg2 companies like arg1" ] using (pfizer, n100)
• pharmaceutical (personalcareitem)
• OE @896 (99.7%) on 23-jan-2015 [ http://www.bloomberg.com/quote/PFE:US http://en.wikipedia.org/wiki/Pfizer http://en.wikipedia.org/wiki/Pfizer http://en.wikipedia.org/wiki/Pfizer http://en.wikipedia.org/wiki/Pfizer http://en.wikipedia.org/wiki/Pfizer  ] using (pfizer, pharmaceutical)
• CPL @1095 (96.9%) on 17-jan-2018 [ "arg2 company like arg1" "arg2 companies like arg1" "arg2 companies including arg1" "arg2 companies such as arg1" "arg2 manufacturers such as arg1" ] using (pfizer, pharmaceutical)
• pharmaceuticals (personalcareitem)
• Seed
• CPL @1108 (50.0%) on 07-jun-2018 [ "arg1 is the largest manufacturer of arg2" ] using (pfizer, pharmaceuticals)
• SEAL @167 (100.0%) on 17-nov-2010 [ 1 2 3 4 5 6 7 8 9 10 11 12 ] using (pfizer, pharmaceuticals)
• OE @805 (100.0%) on 20-jan-2014 [   ] using (pfizer, pharmaceuticals)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentinteractswithagent,concept:personbelongstoorganization,concept:companyeconomicsector" "Y~_X0~concept:agentcollaborateswithagent,concept:personbelongstoorganization,concept:companyeconomicsector" "Y~_X0~concept:agentinteractswithagent,concept:worksfor,concept:companyeconomicsector" "Y~_X0~concept:agentcollaborateswithagent,concept:worksfor,concept:companyeconomicsector" "Y~_X0~concept:agentinteractswithagent,concept:agentinteractswithagent,concept:companyeconomicsector" ] using (pfizer, pharmaceuticals)
• industry (physicalaction)
• CPL @1097 (93.8%) on 19-jan-2018 [ "arg2 giant such as arg1" "arg2 companies such as arg1" "arg2 partners include arg1" "arg2 giants including arg1" ] using (pfizer, industry)
• pharmaceutical (politicsissue)
• OE @896 (99.7%) on 23-jan-2015 [ http://www.bloomberg.com/quote/PFE:US http://en.wikipedia.org/wiki/Pfizer http://en.wikipedia.org/wiki/Pfizer http://en.wikipedia.org/wiki/Pfizer http://en.wikipedia.org/wiki/Pfizer http://en.wikipedia.org/wiki/Pfizer  ] using (pfizer, pharmaceutical)
• CPL @1095 (96.9%) on 17-jan-2018 [ "arg2 company like arg1" "arg2 companies like arg1" "arg2 companies including arg1" "arg2 companies such as arg1" "arg2 manufacturers such as arg1" ] using (pfizer, pharmaceutical)
• industry (stadiumoreventvenue)
• CPL @1097 (93.8%) on 19-jan-2018 [ "arg2 giant such as arg1" "arg2 companies such as arg1" "arg2 partners include arg1" "arg2 giants including arg1" ] using (pfizer, industry)
• device
• CPL @1097 (87.5%) on 19-jan-2018 [ "arg2 companies such as arg1" "arg2 manufacturers such as arg1" "arg2 companies like arg1" ] using (pfizer, device)
• competeswith
• journal (book)
• CPL @1109 (50.0%) on 12-jun-2018 [ "arg1 and the Wall Street arg2" ] using (pfizer, journal)
• CPL @1109 (50.0%) on 12-jun-2018 [ "arg1 and the Wall Street arg2" ] using (journal, pfizer)
• eisai (company)
• CPL @1109 (50.0%) on 12-jun-2018 [ "arg2 Co and arg1" ] using (pfizer_inc, eisai)
• CPL @1109 (50.0%) on 12-jun-2018 [ "arg2 Co and arg1" ] using (eisai, pfizer_inc)
• journal (hobby)
• CPL @1109 (50.0%) on 12-jun-2018 [ "arg1 and the Wall Street arg2" ] using (pfizer, journal)
• CPL @1109 (50.0%) on 12-jun-2018 [ "arg1 and the Wall Street arg2" ] using (journal, pfizer)
• journal (male)
• CPL @1109 (50.0%) on 12-jun-2018 [ "arg1 and the Wall Street arg2" ] using (pfizer, journal)
• CPL @1109 (50.0%) on 12-jun-2018 [ "arg1 and the Wall Street arg2" ] using (journal, pfizer)
• journal (musicartist)
• CPL @1109 (50.0%) on 12-jun-2018 [ "arg1 and the Wall Street arg2" ] using (pfizer, journal)
• CPL @1109 (50.0%) on 12-jun-2018 [ "arg1 and the Wall Street arg2" ] using (journal, pfizer)
• journal (officeitem)
• CPL @1109 (50.0%) on 12-jun-2018 [ "arg1 and the Wall Street arg2" ] using (pfizer, journal)
• CPL @1109 (50.0%) on 12-jun-2018 [ "arg1 and the Wall Street arg2" ] using (journal, pfizer)
• journal (planet)
• CPL @1109 (50.0%) on 12-jun-2018 [ "arg1 and the Wall Street arg2" ] using (pfizer, journal)
• CPL @1109 (50.0%) on 12-jun-2018 [ "arg1 and the Wall Street arg2" ] using (journal, pfizer)
• bristol_myers_squibb (politician)
• CPL @1115 (50.0%) on 27-aug-2018 [ "arg1 Co and arg2" ] using (pfizer, bristol_myers_squibb)
• CPL @1115 (50.0%) on 27-aug-2018 [ "arg1 Co and arg2" ] using (bristol_myers_squibb, pfizer)
• bristol_myers_squibb (product)
• CPL @1115 (50.0%) on 27-aug-2018 [ "arg1 Co and arg2" ] using (bristol_myers_squibb, pfizer)
• CPL @1115 (50.0%) on 27-aug-2018 [ "arg1 Co and arg2" ] using (pfizer, bristol_myers_squibb)
• bristol_myers_squibb (radiostation)
• CPL @1115 (50.0%) on 27-aug-2018 [ "arg1 Co and arg2" ] using (pfizer, bristol_myers_squibb)
• CPL @1115 (50.0%) on 27-aug-2018 [ "arg1 Co and arg2" ] using (bristol_myers_squibb, pfizer)
• journal (terroristorganization)
• CPL @1109 (50.0%) on 12-jun-2018 [ "arg1 and the Wall Street arg2" ] using (pfizer, journal)
• CPL @1109 (50.0%) on 12-jun-2018 [ "arg1 and the Wall Street arg2" ] using (journal, pfizer)
• roche (winery)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentcollaborateswithagent,concept:proxyfor,concept:competeswith" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcontrols,concept:competeswith" "Y~_X0~concept:agentcollaborateswithagent,concept:agentleadsorganization,concept:competeswith" "Y~_X0~concept:worker,concept:proxyfor,concept:competeswith" "Y~_X0~concept:organizationhasperson,concept:proxyfor,concept:competeswith" ] using (pfizer, roche)
• SEAL @623 (100.0%) on 10-aug-2012 [ 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 ] using (pfizer, roche)
• Seed
• OE @803 (99.1%) on 13-jan-2014 [   ] using (roche, pfizer)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentcollaborateswithagent,concept:proxyfor,concept:competeswith" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcontrols,concept:competeswith" "Y~_X0~concept:agentcollaborateswithagent,concept:agentleadsorganization,concept:competeswith" "Y~_X0~concept:worker,concept:proxyfor,concept:competeswith" "Y~_X0~concept:organizationhasperson,concept:proxyfor,concept:competeswith" ] using (roche, pfizer)
• SEAL @623 (100.0%) on 10-aug-2012 [ 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 ] using (roche, pfizer)
• Seed
• OE @803 (99.1%) on 13-jan-2014 [   ] using (pfizer, roche)
• hasofficeincity
• center (agriculturalproduct)
• CPL @1112 (50.0%) on 20-jul-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• center_fielders_torii_hunter
• CPL @1112 (50.0%) on 20-jul-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• center (attraction)
• CPL @1112 (50.0%) on 20-jul-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• new_york_city_metropolitan_area
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:organizationheadquarteredincity" "Y~X0~concept:organizationheadquarteredincity,concept:companiesheadquarteredhere,concept:organizationheadquarteredincity" "Y~_z-concept:country:usa~concept:countrystates,concept:statecontainscity" "Y~X0~concept:organizationheadquarteredincity,concept:proxyfor,concept:proxyof" "Y~X0~concept:organizationheadquarteredincity,concept:proxyfor,concept:mutualproxyfor" ] using (pfizer, new_york_city_metropolitan_area)
• center (bodypart)
• CPL @1112 (50.0%) on 20-jul-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• center001
• CPL @1112 (50.0%) on 20-jul-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• center (buildingfeature)
• CPL @1112 (50.0%) on 20-jul-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• center (charactertrait)
• CPL @1112 (50.0%) on 20-jul-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• new_york (company)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:organizationheadquarteredincity" "Y~X0~concept:organizationheadquarteredincity,concept:companiesheadquarteredhere,concept:organizationheadquarteredincity" "Y~_z-concept:country:usa~concept:countrystates,concept:statecontainscity" "Y~X0~concept:organizationheadquarteredincity,concept:proxyfor,concept:proxyof" "Y~X0~concept:organizationheadquarteredincity,concept:proxyfor,concept:mutualproxyfor" ] using (pfizer, new_york)
• OE @878 (99.2%) on 11-oct-2014 [ http://topics.nytimes.com/top/news/business/companies/pfizer_inc/index.html http://en.wikipedia.org/wiki/Pfizer http://en.wikipedia.org/wiki/Pfizer http://topics.nytimes.com/top/news/business/companies/pfizer_inc/index.html  ] using (pfizer, new_york)
• SEAL @36 (50.0%) on 27-jan-2010 [ 1 ] using (pfizer, new_york)
• nueva_york (company)
• OE @962 (100.0%) on 05-dec-2015 [ http://www.businesswire.com/news/home/20110125006020/en/Pfizer-Announces-York-City%E2%80%99s-Top-Research-Hospitals http://www.businesswire.com/news/home/20110125006020/en/Pfizer-Announces-York-City%E2%80%99s-Top-Research-Hospitals http://www.businesswire.com/news/home/20110125006020/en/Pfizer-Announces-York-City%E2%80%99s-Top-Research-Hospitals http://www.businesswire.com/news/home/20110125006020/en/Pfizer-Announces-York-City%E2%80%99s-Top-Research-Hospitals http://en.wikipedia.org/wiki/Pfizer  ] using (pfizer, new_york_city)
• CPL @1107 (75.0%) on 24-may-2018 [ "arg1 world headquarters in arg2" "arg1 corporate headquarters in arg2" ] using (pfizer, new_york_city)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:organizationheadquarteredincity" "Y~X0~concept:organizationheadquarteredincity,concept:companiesheadquarteredhere,concept:organizationheadquarteredincity" "Y~_z-concept:country:usa~concept:countrystates,concept:statecontainscity" "Y~X0~concept:organizationheadquarteredincity,concept:proxyfor,concept:proxyof" "Y~X0~concept:organizationheadquarteredincity,concept:proxyfor,concept:mutualproxyfor" ] using (pfizer, new_york_city)
• center (consumerelectronicitem)
• CPL @1112 (50.0%) on 20-jul-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• _uk
• CPL @1112 (50.0%) on 20-jul-2018 [ "arg1 Central Research in arg2" ] using (pfizer, uk)
• sandwich (food)
• CPL @1100 (87.5%) on 31-jan-2018 [ "arg1 Laboratories in arg2" "arg1 Global Research and Development in arg2" "arg1 Central Research in arg2" ] using (pfizer, sandwich)
• connecticut (geopoliticallocation)
• CPL @1109 (75.0%) on 12-jun-2018 [ "arg1 Global Research and Development in arg2" "arg1 Central Research in arg2" ] using (pfizer, connecticut)
• center (highway)
• CPL @1112 (50.0%) on 20-jul-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• center (hospital)
• CPL @1112 (50.0%) on 20-jul-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• sandwich (island)
• CPL @1100 (87.5%) on 31-jan-2018 [ "arg1 Laboratories in arg2" "arg1 Global Research and Development in arg2" "arg1 Central Research in arg2" ] using (pfizer, sandwich)
• center (jobposition)
• CPL @1112 (50.0%) on 20-jul-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• center (kitchenitem)
• CPL @1112 (50.0%) on 20-jul-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• nueva_york (male)
• OE @962 (100.0%) on 05-dec-2015 [ http://www.businesswire.com/news/home/20110125006020/en/Pfizer-Announces-York-City%E2%80%99s-Top-Research-Hospitals http://www.businesswire.com/news/home/20110125006020/en/Pfizer-Announces-York-City%E2%80%99s-Top-Research-Hospitals http://www.businesswire.com/news/home/20110125006020/en/Pfizer-Announces-York-City%E2%80%99s-Top-Research-Hospitals http://www.businesswire.com/news/home/20110125006020/en/Pfizer-Announces-York-City%E2%80%99s-Top-Research-Hospitals http://en.wikipedia.org/wiki/Pfizer  ] using (pfizer, new_york_city)
• CPL @1107 (75.0%) on 24-may-2018 [ "arg1 world headquarters in arg2" "arg1 corporate headquarters in arg2" ] using (pfizer, new_york_city)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:organizationheadquarteredincity" "Y~X0~concept:organizationheadquarteredincity,concept:companiesheadquarteredhere,concept:organizationheadquarteredincity" "Y~_z-concept:country:usa~concept:countrystates,concept:statecontainscity" "Y~X0~concept:organizationheadquarteredincity,concept:proxyfor,concept:proxyof" "Y~X0~concept:organizationheadquarteredincity,concept:proxyfor,concept:mutualproxyfor" ] using (pfizer, new_york_city)
• center (mediatype)
• CPL @1112 (50.0%) on 20-jul-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• center (medicalprocedure)
• CPL @1112 (50.0%) on 20-jul-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• center (mlsoftware)
• CPL @1112 (50.0%) on 20-jul-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• center (monument)
• CPL @1112 (50.0%) on 20-jul-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• center (museum)
• CPL @1112 (50.0%) on 20-jul-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• center (musicalbum)
• CPL @1112 (50.0%) on 20-jul-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• center (nondiseasecondition)
• CPL @1112 (50.0%) on 20-jul-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• center (person)
• CPL @1112 (50.0%) on 20-jul-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• center (personasia)
• CPL @1112 (50.0%) on 20-jul-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• center (personeurope)
• CPL @1112 (50.0%) on 20-jul-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• new_york (personnorthamerica)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:organizationheadquarteredincity" "Y~X0~concept:organizationheadquarteredincity,concept:companiesheadquarteredhere,concept:organizationheadquarteredincity" "Y~_z-concept:country:usa~concept:countrystates,concept:statecontainscity" "Y~X0~concept:organizationheadquarteredincity,concept:proxyfor,concept:proxyof" "Y~X0~concept:organizationheadquarteredincity,concept:proxyfor,concept:mutualproxyfor" ] using (pfizer, new_york)
• OE @878 (99.2%) on 11-oct-2014 [ http://topics.nytimes.com/top/news/business/companies/pfizer_inc/index.html http://en.wikipedia.org/wiki/Pfizer http://en.wikipedia.org/wiki/Pfizer http://topics.nytimes.com/top/news/business/companies/pfizer_inc/index.html  ] using (pfizer, new_york)
• SEAL @36 (50.0%) on 27-jan-2010 [ 1 ] using (pfizer, new_york)
• center (shoppingmall)
• CPL @1112 (50.0%) on 20-jul-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• center (skyscraper)
• CPL @1112 (50.0%) on 20-jul-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• uk (sportsteam)
• CPL @1112 (50.0%) on 20-jul-2018 [ "arg1 Central Research in arg2" ] using (pfizer, uk)
• center (sportsteamposition)
• CPL @1112 (50.0%) on 20-jul-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• center (stadiumoreventvenue)
• CPL @1112 (50.0%) on 20-jul-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• connecticut (stateorprovince)
• CPL @1109 (75.0%) on 12-jun-2018 [ "arg1 Global Research and Development in arg2" "arg1 Central Research in arg2" ] using (pfizer, connecticut)
• new_york (stateorprovince)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:organizationheadquarteredincity" "Y~X0~concept:organizationheadquarteredincity,concept:companiesheadquarteredhere,concept:organizationheadquarteredincity" "Y~_z-concept:country:usa~concept:countrystates,concept:statecontainscity" "Y~X0~concept:organizationheadquarteredincity,concept:proxyfor,concept:proxyof" "Y~X0~concept:organizationheadquarteredincity,concept:proxyfor,concept:mutualproxyfor" ] using (pfizer, new_york)
• OE @878 (99.2%) on 11-oct-2014 [ http://topics.nytimes.com/top/news/business/companies/pfizer_inc/index.html http://en.wikipedia.org/wiki/Pfizer http://en.wikipedia.org/wiki/Pfizer http://topics.nytimes.com/top/news/business/companies/pfizer_inc/index.html  ] using (pfizer, new_york)
• SEAL @36 (50.0%) on 27-jan-2010 [ 1 ] using (pfizer, new_york)
• center (televisionshow)
• CPL @1112 (50.0%) on 20-jul-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• center (tool)
• CPL @1112 (50.0%) on 20-jul-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• center (trainstation)
• CPL @1112 (50.0%) on 20-jul-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• connecticut (university)
• CPL @1109 (75.0%) on 12-jun-2018 [ "arg1 Global Research and Development in arg2" "arg1 Central Research in arg2" ] using (pfizer, connecticut)
• center (visualizableattribute)
• CPL @1112 (50.0%) on 20-jul-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• center (visualizablescene)
• CPL @1112 (50.0%) on 20-jul-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• new_york (visualizablescene)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:organizationheadquarteredincity" "Y~X0~concept:organizationheadquarteredincity,concept:companiesheadquarteredhere,concept:organizationheadquarteredincity" "Y~_z-concept:country:usa~concept:countrystates,concept:statecontainscity" "Y~X0~concept:organizationheadquarteredincity,concept:proxyfor,concept:proxyof" "Y~X0~concept:organizationheadquarteredincity,concept:proxyfor,concept:mutualproxyfor" ] using (pfizer, new_york)
• OE @878 (99.2%) on 11-oct-2014 [ http://topics.nytimes.com/top/news/business/companies/pfizer_inc/index.html http://en.wikipedia.org/wiki/Pfizer http://en.wikipedia.org/wiki/Pfizer http://topics.nytimes.com/top/news/business/companies/pfizer_inc/index.html  ] using (pfizer, new_york)
• SEAL @36 (50.0%) on 27-jan-2010 [ 1 ] using (pfizer, new_york)
• headquarteredin
• manhattan (actor)
• CPL @1115 (50.0%) on 27-aug-2018 [ "arg1 Pharmaceuticals in arg2" ] using (pfizer, manhattan)
• center (agriculturalproduct)
• CPL @1107 (50.0%) on 24-may-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• center_fielders_torii_hunter
• CPL @1107 (50.0%) on 24-may-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• center (attraction)
• CPL @1107 (50.0%) on 24-may-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• new_york_city_metropolitan_area
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:agentinteractswithagent,concept:agentinteractswithagent,concept:organizationheadquarteredincity" "Y~X0~concept:agentinteractswithagent,concept:agentinteractswithagent,concept:hasofficeincity" "Y~X0~concept:agentinteractswithagent,concept:agentinteractswithagent,concept:agentactsinlocation" "Y~X0~concept:agentinteractswithagent,concept:agentinteractswithagent,concept:organizationactsinlocation" "Y~X0~concept:agentinteractswithagent,concept:agentinteractswithagent,concept:agentrelatedtolocation" ] using (pfizer, new_york_city_metropolitan_area)
• icos (biotechcompany)
• CPL @1105 (50.0%) on 25-mar-2018 [ "arg1 Pharmaceuticals in arg2" ] using (pfizer, icos)
• center (bodypart)
• CPL @1107 (50.0%) on 24-may-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• center001
• CPL @1107 (50.0%) on 24-may-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• center (buildingfeature)
• CPL @1107 (50.0%) on 24-may-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• center (charactertrait)
• CPL @1107 (50.0%) on 24-may-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• manhattan (city)
• CPL @1115 (50.0%) on 27-aug-2018 [ "arg1 Pharmaceuticals in arg2" ] using (pfizer, manhattan)
• new_york (company)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:agentinteractswithagent,concept:agentinteractswithagent,concept:organizationheadquarteredincity" "Y~X0~concept:agentinteractswithagent,concept:agentinteractswithagent,concept:hasofficeincity" "Y~X0~concept:agentinteractswithagent,concept:agentinteractswithagent,concept:agentactsinlocation" "Y~X0~concept:agentinteractswithagent,concept:agentinteractswithagent,concept:organizationactsinlocation" "Y~X0~concept:agentinteractswithagent,concept:agentinteractswithagent,concept:agentrelatedtolocation" ] using (pfizer, new_york)
• OE @965 (100.0%) on 17-dec-2015 [ http://en.wikipedia.org/wiki/Pfizer http://en.wikipedia.org/wiki/Pfizer http://topics.nytimes.com/top/news/business/companies/pfizer_inc/index.html http://topics.nytimes.com/top/news/business/companies/pfizer_inc/index.html  ] using (pfizer, new_york)
• SEAL @113 (75.0%) on 03-jun-2010 [ 1 2 ] using (pfizer, new_york)
• nueva_york (company)
• OE @883 (100.0%) on 30-oct-2014 [ http://www.businesswire.com/news/home/20110125006020/en/Pfizer-Announces-York-City%E2%80%99s-Top-Research-Hospitals http://www.businesswire.com/news/home/20110125006020/en/Pfizer-Announces-York-City%E2%80%99s-Top-Research-Hospitals http://www.pfizer.com/news/press-release/press-release-archive-detail/pfizer_announces_seven_of_new_york_city_s_top_research_hospitals_join_global_centers_for_therapeutic_innovation http://www.businesswire.com/news/home/20110125006020/en/Pfizer-Announces-York-City%E2%80%99s-Top-Research-Hospitals http://en.wikipedia.org/wiki/Pfizer http://www.businesswire.com/news/home/20110125006020/en/Pfizer-Announces-York-City%E2%80%99s-Top-Research-Hospitals  ] using (pfizer, new_york_city)
• Human feedback from bkisiel @840 on 23-may-2014 [ "pfizer headquarteredin new_york_city", Action=(+headquarteredin) (from NELL.08m.840.SSFeedback.csv) ] using (pfizer, new_york_city)
• CPL @1104 (87.5%) on 18-mar-2018 [ "arg1 Pharmaceuticals in arg2" "arg1 world headquarters in arg2" "arg1 Finance Manager Salaries in arg2" ] using (pfizer, new_york_city)
• SEAL @580 (50.0%) on 27-may-2012 [ 1 ] using (pfizer, new_york_city)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:agentinteractswithagent,concept:agentinteractswithagent,concept:organizationheadquarteredincity" "Y~X0~concept:agentinteractswithagent,concept:agentinteractswithagent,concept:hasofficeincity" "Y~X0~concept:agentinteractswithagent,concept:agentinteractswithagent,concept:agentactsinlocation" "Y~X0~concept:agentinteractswithagent,concept:agentinteractswithagent,concept:organizationactsinlocation" "Y~X0~concept:agentinteractswithagent,concept:agentinteractswithagent,concept:agentrelatedtolocation" ] using (pfizer, new_york_city)
• icos (conference)
• CPL @1105 (50.0%) on 25-mar-2018 [ "arg1 Pharmaceuticals in arg2" ] using (pfizer, icos)
• center (consumerelectronicitem)
• CPL @1107 (50.0%) on 24-may-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• _uk
• CPL @1104 (75.0%) on 18-mar-2018 [ "arg1 Pharmaceuticals in arg2" "arg1 Central Research in arg2" ] using (pfizer, uk)
• kent (county)
• CPL @1104 (75.0%) on 18-mar-2018 [ "arg1 Pharmaceuticals in arg2" "arg1 Central Research in arg2" ] using (pfizer, kent)
• new_south_wales (county)
• CPL @1113 (50.0%) on 03-aug-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, england)
• san_diego (county)
• CPL @1100 (50.0%) on 31-jan-2018 [ "arg1 Pharmaceuticals in arg2" ] using (pfizer, san_diego)
• chairman (ethnicgroup)
• CPL @1113 (50.0%) on 03-aug-2018 [ "arg1 Central Research in arg2" ] using (pfizer, chairman)
• chairman (eventoutcome)
• CPL @1113 (50.0%) on 03-aug-2018 [ "arg1 Central Research in arg2" ] using (pfizer, chairman)
• sandwich (food)
• CPL @1096 (87.5%) on 18-jan-2018 [ "arg1 Laboratories in arg2" "arg1 Global Research and Development in arg2" "arg1 Central Research in arg2" ] using (pfizer, sandwich)
• connecticut (geopoliticallocation)
• CPL @1104 (87.5%) on 18-mar-2018 [ "arg1 Global Research and Development in arg2" "arg1 Central Research in arg2" "arg1 Pharmaceuticals in arg2" ] using (pfizer, connecticut)
• new_south_wales (geopoliticallocation)
• CPL @1113 (50.0%) on 03-aug-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, england)
• surrey (geopoliticallocation)
• CPL @1105 (50.0%) on 25-mar-2018 [ "arg1 Consumer Healthcare in arg2" ] using (pfizer, surrey)
• chairman (governmentorganization)
• CPL @1113 (50.0%) on 03-aug-2018 [ "arg1 Central Research in arg2" ] using (pfizer, chairman)
• center (highway)
• CPL @1107 (50.0%) on 24-may-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• center (hospital)
• CPL @1107 (50.0%) on 24-may-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• england (island)
• CPL @1113 (50.0%) on 03-aug-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, england)
• manhattan (island)
• CPL @1115 (50.0%) on 27-aug-2018 [ "arg1 Pharmaceuticals in arg2" ] using (pfizer, manhattan)
• sandwich (island)
• CPL @1096 (87.5%) on 18-jan-2018 [ "arg1 Laboratories in arg2" "arg1 Global Research and Development in arg2" "arg1 Central Research in arg2" ] using (pfizer, sandwich)
• center (jobposition)
• CPL @1107 (50.0%) on 24-may-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• center (kitchenitem)
• CPL @1107 (50.0%) on 24-may-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• irvine (legume)
• SEAL @113 (50.0%) on 03-jun-2010 [ 1 ] using (pfizer, irvine)
• groton_ct
• CPL @1115 (50.0%) on 27-aug-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, groton_ct)
• nueva_york (male)
• OE @883 (100.0%) on 30-oct-2014 [ http://www.businesswire.com/news/home/20110125006020/en/Pfizer-Announces-York-City%E2%80%99s-Top-Research-Hospitals http://www.businesswire.com/news/home/20110125006020/en/Pfizer-Announces-York-City%E2%80%99s-Top-Research-Hospitals http://www.pfizer.com/news/press-release/press-release-archive-detail/pfizer_announces_seven_of_new_york_city_s_top_research_hospitals_join_global_centers_for_therapeutic_innovation http://www.businesswire.com/news/home/20110125006020/en/Pfizer-Announces-York-City%E2%80%99s-Top-Research-Hospitals http://en.wikipedia.org/wiki/Pfizer http://www.businesswire.com/news/home/20110125006020/en/Pfizer-Announces-York-City%E2%80%99s-Top-Research-Hospitals  ] using (pfizer, new_york_city)
• Human feedback from bkisiel @840 on 23-may-2014 [ "pfizer headquarteredin new_york_city", Action=(+headquarteredin) (from NELL.08m.840.SSFeedback.csv) ] using (pfizer, new_york_city)
• CPL @1104 (87.5%) on 18-mar-2018 [ "arg1 Pharmaceuticals in arg2" "arg1 world headquarters in arg2" "arg1 Finance Manager Salaries in arg2" ] using (pfizer, new_york_city)
• SEAL @580 (50.0%) on 27-may-2012 [ 1 ] using (pfizer, new_york_city)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:agentinteractswithagent,concept:agentinteractswithagent,concept:organizationheadquarteredincity" "Y~X0~concept:agentinteractswithagent,concept:agentinteractswithagent,concept:hasofficeincity" "Y~X0~concept:agentinteractswithagent,concept:agentinteractswithagent,concept:agentactsinlocation" "Y~X0~concept:agentinteractswithagent,concept:agentinteractswithagent,concept:organizationactsinlocation" "Y~X0~concept:agentinteractswithagent,concept:agentinteractswithagent,concept:agentrelatedtolocation" ] using (pfizer, new_york_city)
• center (mediatype)
• CPL @1107 (50.0%) on 24-may-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• center (medicalprocedure)
• CPL @1107 (50.0%) on 24-may-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• center (mlsoftware)
• CPL @1107 (50.0%) on 24-may-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• center (monument)
• CPL @1107 (50.0%) on 24-may-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• center (museum)
• CPL @1107 (50.0%) on 24-may-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• center (musicalbum)
• CPL @1107 (50.0%) on 24-may-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• manhattan (musicsong)
• CPL @1115 (50.0%) on 27-aug-2018 [ "arg1 Pharmaceuticals in arg2" ] using (pfizer, manhattan)
• center (nondiseasecondition)
• CPL @1107 (50.0%) on 24-may-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• new_zealand
• CPL @1113 (50.0%) on 03-aug-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, england)
• center (person)
• CPL @1107 (50.0%) on 24-may-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• chairman (person)
• CPL @1113 (50.0%) on 03-aug-2018 [ "arg1 Central Research in arg2" ] using (pfizer, chairman)
• england (person)
• CPL @1113 (50.0%) on 03-aug-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, england)
• kent (person)
• CPL @1104 (75.0%) on 18-mar-2018 [ "arg1 Pharmaceuticals in arg2" "arg1 Central Research in arg2" ] using (pfizer, kent)
• center (personasia)
• CPL @1107 (50.0%) on 24-may-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• center (personeurope)
• CPL @1107 (50.0%) on 24-may-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• new_york (personnorthamerica)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:agentinteractswithagent,concept:agentinteractswithagent,concept:organizationheadquarteredincity" "Y~X0~concept:agentinteractswithagent,concept:agentinteractswithagent,concept:hasofficeincity" "Y~X0~concept:agentinteractswithagent,concept:agentinteractswithagent,concept:agentactsinlocation" "Y~X0~concept:agentinteractswithagent,concept:agentinteractswithagent,concept:organizationactsinlocation" "Y~X0~concept:agentinteractswithagent,concept:agentinteractswithagent,concept:agentrelatedtolocation" ] using (pfizer, new_york)
• OE @965 (100.0%) on 17-dec-2015 [ http://en.wikipedia.org/wiki/Pfizer http://en.wikipedia.org/wiki/Pfizer http://topics.nytimes.com/top/news/business/companies/pfizer_inc/index.html http://topics.nytimes.com/top/news/business/companies/pfizer_inc/index.html  ] using (pfizer, new_york)
• SEAL @113 (75.0%) on 03-jun-2010 [ 1 2 ] using (pfizer, new_york)
• chairman (politicaloffice)
• CPL @1113 (50.0%) on 03-aug-2018 [ "arg1 Central Research in arg2" ] using (pfizer, chairman)
• pearl_river
• CPL @1099 (75.0%) on 23-jan-2018 [ "arg1 Pharmaceuticals in arg2" "arg1 Laboratories in arg2" ] using (pfizer, pearl_river)
• kent (room)
• CPL @1104 (75.0%) on 18-mar-2018 [ "arg1 Pharmaceuticals in arg2" "arg1 Central Research in arg2" ] using (pfizer, kent)
• center (shoppingmall)
• CPL @1107 (50.0%) on 24-may-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• center (skyscraper)
• CPL @1107 (50.0%) on 24-may-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• uk (sportsteam)
• CPL @1104 (75.0%) on 18-mar-2018 [ "arg1 Pharmaceuticals in arg2" "arg1 Central Research in arg2" ] using (pfizer, uk)
• center (sportsteamposition)
• CPL @1107 (50.0%) on 24-may-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• center (stadiumoreventvenue)
• CPL @1107 (50.0%) on 24-may-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• connecticut (stateorprovince)
• CPL @1104 (87.5%) on 18-mar-2018 [ "arg1 Global Research and Development in arg2" "arg1 Central Research in arg2" "arg1 Pharmaceuticals in arg2" ] using (pfizer, connecticut)
• new_york (stateorprovince)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:agentinteractswithagent,concept:agentinteractswithagent,concept:organizationheadquarteredincity" "Y~X0~concept:agentinteractswithagent,concept:agentinteractswithagent,concept:hasofficeincity" "Y~X0~concept:agentinteractswithagent,concept:agentinteractswithagent,concept:agentactsinlocation" "Y~X0~concept:agentinteractswithagent,concept:agentinteractswithagent,concept:organizationactsinlocation" "Y~X0~concept:agentinteractswithagent,concept:agentinteractswithagent,concept:agentrelatedtolocation" ] using (pfizer, new_york)
• OE @965 (100.0%) on 17-dec-2015 [ http://en.wikipedia.org/wiki/Pfizer http://en.wikipedia.org/wiki/Pfizer http://topics.nytimes.com/top/news/business/companies/pfizer_inc/index.html http://topics.nytimes.com/top/news/business/companies/pfizer_inc/index.html  ] using (pfizer, new_york)
• SEAL @113 (75.0%) on 03-jun-2010 [ 1 2 ] using (pfizer, new_york)
• san_diego (stateorprovince)
• CPL @1100 (50.0%) on 31-jan-2018 [ "arg1 Pharmaceuticals in arg2" ] using (pfizer, san_diego)
• center (televisionshow)
• CPL @1107 (50.0%) on 24-may-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• san_diego (televisionstation)
• CPL @1100 (50.0%) on 31-jan-2018 [ "arg1 Pharmaceuticals in arg2" ] using (pfizer, san_diego)
• center (tool)
• CPL @1107 (50.0%) on 24-may-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• center (trainstation)
• CPL @1107 (50.0%) on 24-may-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• connecticut (university)
• CPL @1104 (87.5%) on 18-mar-2018 [ "arg1 Global Research and Development in arg2" "arg1 Central Research in arg2" "arg1 Pharmaceuticals in arg2" ] using (pfizer, connecticut)
• center (visualizableattribute)
• CPL @1107 (50.0%) on 24-may-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• center (visualizablescene)
• CPL @1107 (50.0%) on 24-may-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• new_york (visualizablescene)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:agentinteractswithagent,concept:agentinteractswithagent,concept:organizationheadquarteredincity" "Y~X0~concept:agentinteractswithagent,concept:agentinteractswithagent,concept:hasofficeincity" "Y~X0~concept:agentinteractswithagent,concept:agentinteractswithagent,concept:agentactsinlocation" "Y~X0~concept:agentinteractswithagent,concept:agentinteractswithagent,concept:organizationactsinlocation" "Y~X0~concept:agentinteractswithagent,concept:agentinteractswithagent,concept:agentrelatedtolocation" ] using (pfizer, new_york)
• OE @965 (100.0%) on 17-dec-2015 [ http://en.wikipedia.org/wiki/Pfizer http://en.wikipedia.org/wiki/Pfizer http://topics.nytimes.com/top/news/business/companies/pfizer_inc/index.html http://topics.nytimes.com/top/news/business/companies/pfizer_inc/index.html  ] using (pfizer, new_york)
• SEAL @113 (75.0%) on 03-jun-2010 [ 1 2 ] using (pfizer, new_york)
• manhattan (wine)
• CPL @1115 (50.0%) on 27-aug-2018 [ "arg1 Pharmaceuticals in arg2" ] using (pfizer, manhattan)
• inverseofbacteriaisthecausativeagentofphysiologicalcondition
• plasmodium
• CPL @1104 (75.0%) on 18-mar-2018 [ "arg1 falciparum arg2" "arg1 vivax arg2" ] using (plasmodium, pfizer)
• mutualproxyfor
• years (agent)
• CPL @1112 (50.0%) on 20-jul-2018 [ "arg1 Mexico for four arg2" ] using (pfizer, years)
• CPL @1112 (50.0%) on 20-jul-2018 [ "arg1 Mexico for four arg2" ] using (years, pfizer)
• new (bathroomitem)
• CPL @1116 (50.0%) on 06-sep-2018 [ "arg1 Jersey and arg2" ] using (new, pfizer)
• CPL @1116 (50.0%) on 06-sep-2018 [ "arg1 Jersey and arg2" ] using (pfizer, new)
• new (bedroomitem)
• CPL @1116 (50.0%) on 06-sep-2018 [ "arg1 Jersey and arg2" ] using (new, pfizer)
• CPL @1116 (50.0%) on 06-sep-2018 [ "arg1 Jersey and arg2" ] using (pfizer, new)
• years (book)
• CPL @1112 (50.0%) on 20-jul-2018 [ "arg1 Mexico for four arg2" ] using (pfizer, years)
• CPL @1112 (50.0%) on 20-jul-2018 [ "arg1 Mexico for four arg2" ] using (years, pfizer)
• years (building)
• CPL @1112 (50.0%) on 20-jul-2018 [ "arg1 Mexico for four arg2" ] using (pfizer, years)
• CPL @1112 (50.0%) on 20-jul-2018 [ "arg1 Mexico for four arg2" ] using (years, pfizer)
• new (coach)
• CPL @1116 (50.0%) on 06-sep-2018 [ "arg1 Jersey and arg2" ] using (new, pfizer)
• CPL @1116 (50.0%) on 06-sep-2018 [ "arg1 Jersey and arg2" ] using (pfizer, new)
• new (election)
• CPL @1116 (50.0%) on 06-sep-2018 [ "arg1 Jersey and arg2" ] using (new, pfizer)
• CPL @1116 (50.0%) on 06-sep-2018 [ "arg1 Jersey and arg2" ] using (pfizer, new)
• new (emotion)
• CPL @1116 (50.0%) on 06-sep-2018 [ "arg1 Jersey and arg2" ] using (new, pfizer)
• CPL @1116 (50.0%) on 06-sep-2018 [ "arg1 Jersey and arg2" ] using (pfizer, new)
• years (emotion)
• CPL @1112 (50.0%) on 20-jul-2018 [ "arg1 Mexico for four arg2" ] using (pfizer, years)
• CPL @1112 (50.0%) on 20-jul-2018 [ "arg1 Mexico for four arg2" ] using (years, pfizer)
• new (eventoutcome)
• CPL @1116 (50.0%) on 06-sep-2018 [ "arg1 Jersey and arg2" ] using (new, pfizer)
• CPL @1116 (50.0%) on 06-sep-2018 [ "arg1 Jersey and arg2" ] using (pfizer, new)
• new (geopoliticallocation)
• CPL @1116 (50.0%) on 06-sep-2018 [ "arg1 Jersey and arg2" ] using (new, pfizer)
• CPL @1116 (50.0%) on 06-sep-2018 [ "arg1 Jersey and arg2" ] using (pfizer, new)
• new (hallwayitem)
• CPL @1116 (50.0%) on 06-sep-2018 [ "arg1 Jersey and arg2" ] using (new, pfizer)
• CPL @1116 (50.0%) on 06-sep-2018 [ "arg1 Jersey and arg2" ] using (pfizer, new)
• years (male)
• CPL @1112 (50.0%) on 20-jul-2018 [ "arg1 Mexico for four arg2" ] using (pfizer, years)
• CPL @1112 (50.0%) on 20-jul-2018 [ "arg1 Mexico for four arg2" ] using (years, pfizer)
• years (mediatype)
• CPL @1112 (50.0%) on 20-jul-2018 [ "arg1 Mexico for four arg2" ] using (pfizer, years)
• CPL @1112 (50.0%) on 20-jul-2018 [ "arg1 Mexico for four arg2" ] using (years, pfizer)
• new (person)
• CPL @1116 (50.0%) on 06-sep-2018 [ "arg1 Jersey and arg2" ] using (new, pfizer)
• CPL @1116 (50.0%) on 06-sep-2018 [ "arg1 Jersey and arg2" ] using (pfizer, new)
• new (politicaloffice)
• CPL @1116 (50.0%) on 06-sep-2018 [ "arg1 Jersey and arg2" ] using (new, pfizer)
• CPL @1116 (50.0%) on 06-sep-2018 [ "arg1 Jersey and arg2" ] using (pfizer, new)
• new (researchproject)
• CPL @1116 (50.0%) on 06-sep-2018 [ "arg1 Jersey and arg2" ] using (new, pfizer)
• CPL @1116 (50.0%) on 06-sep-2018 [ "arg1 Jersey and arg2" ] using (pfizer, new)
• new (room)
• CPL @1116 (50.0%) on 06-sep-2018 [ "arg1 Jersey and arg2" ] using (new, pfizer)
• CPL @1116 (50.0%) on 06-sep-2018 [ "arg1 Jersey and arg2" ] using (pfizer, new)
• years (sociopolitical)
• CPL @1112 (50.0%) on 20-jul-2018 [ "arg1 Mexico for four arg2" ] using (pfizer, years)
• CPL @1112 (50.0%) on 20-jul-2018 [ "arg1 Mexico for four arg2" ] using (years, pfizer)
• new (sportsleague)
• CPL @1116 (50.0%) on 06-sep-2018 [ "arg1 Jersey and arg2" ] using (new, pfizer)
• CPL @1116 (50.0%) on 06-sep-2018 [ "arg1 Jersey and arg2" ] using (pfizer, new)
• new (tableitem)
• CPL @1116 (50.0%) on 06-sep-2018 [ "arg1 Jersey and arg2" ] using (new, pfizer)
• CPL @1116 (50.0%) on 06-sep-2018 [ "arg1 Jersey and arg2" ] using (pfizer, new)
• new (traditionalgame)
• CPL @1116 (50.0%) on 06-sep-2018 [ "arg1 Jersey and arg2" ] using (new, pfizer)
• CPL @1116 (50.0%) on 06-sep-2018 [ "arg1 Jersey and arg2" ] using (pfizer, new)
• new (vertebrate)
• CPL @1116 (50.0%) on 06-sep-2018 [ "arg1 Jersey and arg2" ] using (new, pfizer)
• CPL @1116 (50.0%) on 06-sep-2018 [ "arg1 Jersey and arg2" ] using (pfizer, new)
• new (videogamesystem)
• CPL @1116 (50.0%) on 06-sep-2018 [ "arg1 Jersey and arg2" ] using (new, pfizer)
• CPL @1116 (50.0%) on 06-sep-2018 [ "arg1 Jersey and arg2" ] using (pfizer, new)
• new (visualizableattribute)
• CPL @1116 (50.0%) on 06-sep-2018 [ "arg1 Jersey and arg2" ] using (new, pfizer)
• CPL @1116 (50.0%) on 06-sep-2018 [ "arg1 Jersey and arg2" ] using (pfizer, new)
• new (weatherphenomenon)
• CPL @1116 (50.0%) on 06-sep-2018 [ "arg1 Jersey and arg2" ] using (new, pfizer)
• CPL @1116 (50.0%) on 06-sep-2018 [ "arg1 Jersey and arg2" ] using (pfizer, new)
• new (year)
• CPL @1116 (50.0%) on 06-sep-2018 [ "arg1 Jersey and arg2" ] using (new, pfizer)
• CPL @1116 (50.0%) on 06-sep-2018 [ "arg1 Jersey and arg2" ] using (pfizer, new)
• organizationheadquarteredincity
• center (agriculturalproduct)
• CPL @1104 (50.0%) on 18-mar-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• center_fielders_torii_hunter
• CPL @1104 (50.0%) on 18-mar-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• center (attraction)
• CPL @1104 (50.0%) on 18-mar-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• new_york_city_metropolitan_area
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:hasofficeincity" "Y~X0~concept:agentinteractswithagent,concept:agentinteractswithagent,concept:organizationactsinlocation" "Y~_z-concept:country:usa~concept:geopoliticallocationcontainsstate,concept:statecontainscity" "Y~X0~concept:hasofficeincity,concept:cityhasairport,concept:atlocation" "Y~_z-concept:country:countries~concept:generalizationof,concept:countrycities" ] using (pfizer, new_york_city_metropolitan_area)
• center (bodypart)
• CPL @1104 (50.0%) on 18-mar-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• center001
• CPL @1104 (50.0%) on 18-mar-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• center (buildingfeature)
• CPL @1104 (50.0%) on 18-mar-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• center (charactertrait)
• CPL @1104 (50.0%) on 18-mar-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• new_york (company)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:hasofficeincity" "Y~X0~concept:agentinteractswithagent,concept:agentinteractswithagent,concept:organizationactsinlocation" "Y~_z-concept:country:usa~concept:geopoliticallocationcontainsstate,concept:statecontainscity" "Y~X0~concept:hasofficeincity,concept:cityhasairport,concept:atlocation" "Y~_z-concept:country:countries~concept:generalizationof,concept:countrycities" ] using (pfizer, new_york)
• OE @1104 (100.0%) on 18-mar-2018 [ http://en.wikipedia.org/wiki/Pfizer http://en.wikipedia.org/wiki/Pfizer http://topics.nytimes.com/top/news/business/companies/pfizer_inc/index.html http://topics.nytimes.com/top/news/business/companies/pfizer_inc/index.html  ] using (pfizer, new_york)
• nueva_york (company)
• CPL @1104 (50.0%) on 18-mar-2018 [ "arg1 world headquarters in arg2" ] using (pfizer, new_york_city)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:hasofficeincity" "Y~X0~concept:agentinteractswithagent,concept:agentinteractswithagent,concept:organizationactsinlocation" "Y~_z-concept:country:usa~concept:geopoliticallocationcontainsstate,concept:statecontainscity" "Y~X0~concept:hasofficeincity,concept:cityhasairport,concept:atlocation" "Y~_z-concept:country:countries~concept:generalizationof,concept:countrycities" ] using (pfizer, new_york_city)
• OE @1021 (89.3%) on 14-oct-2016 [ http://www.businesswire.com/news/home/20110125006020/en/Pfizer-Announces-York-City%E2%80%99s-Top-Research-Hospitals http://www.businesswire.com/news/home/20110125006020/en/Pfizer-Announces-York-City%E2%80%99s-Top-Research-Hospitals http://www.businesswire.com/news/home/20110125006020/en/Pfizer-Announces-York-City%E2%80%99s-Top-Research-Hospitals http://en.wikipedia.org/wiki/Pfizer http://www.businesswire.com/news/home/20110125006020/en/Pfizer-Announces-York-City%E2%80%99s-Top-Research-Hospitals  ] using (pfizer, new_york_city)
• center (consumerelectronicitem)
• CPL @1104 (50.0%) on 18-mar-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• the_united_kingdom
• CPL @1115 (50.0%) on 27-aug-2018 [ "arg1 Central Research in arg2" ] using (pfizer, united_kingdom)
• _uk
• CPL @1104 (50.0%) on 18-mar-2018 [ "arg1 Central Research in arg2" ] using (pfizer, uk)
• kent (county)
• CPL @1104 (50.0%) on 18-mar-2018 [ "arg1 Central Research in arg2" ] using (pfizer, kent)
• new_south_wales (county)
• CPL @1107 (50.0%) on 24-may-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, england)
• chairman (ethnicgroup)
• CPL @1107 (50.0%) on 24-may-2018 [ "arg1 Central Research in arg2" ] using (pfizer, chairman)
• chairman (eventoutcome)
• CPL @1107 (50.0%) on 24-may-2018 [ "arg1 Central Research in arg2" ] using (pfizer, chairman)
• sandwich (food)
• CPL @1104 (75.0%) on 18-mar-2018 [ "arg1 Global Research and Development in arg2" "arg1 Central Research in arg2" ] using (pfizer, sandwich)
• connecticut (geopoliticallocation)
• CPL @1104 (75.0%) on 18-mar-2018 [ "arg1 Global Research and Development in arg2" "arg1 Central Research in arg2" ] using (pfizer, connecticut)
• new_south_wales (geopoliticallocation)
• CPL @1107 (50.0%) on 24-may-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, england)
• chairman (governmentorganization)
• CPL @1107 (50.0%) on 24-may-2018 [ "arg1 Central Research in arg2" ] using (pfizer, chairman)
• center (highway)
• CPL @1104 (50.0%) on 18-mar-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• center (hospital)
• CPL @1104 (50.0%) on 18-mar-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• england (island)
• CPL @1107 (50.0%) on 24-may-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, england)
• sandwich (island)
• CPL @1104 (75.0%) on 18-mar-2018 [ "arg1 Global Research and Development in arg2" "arg1 Central Research in arg2" ] using (pfizer, sandwich)
• center (jobposition)
• CPL @1104 (50.0%) on 18-mar-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• center (kitchenitem)
• CPL @1104 (50.0%) on 18-mar-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• groton_ct
• CPL @1107 (50.0%) on 24-may-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, groton_ct)
• nueva_york (male)
• CPL @1104 (50.0%) on 18-mar-2018 [ "arg1 world headquarters in arg2" ] using (pfizer, new_york_city)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:hasofficeincity" "Y~X0~concept:agentinteractswithagent,concept:agentinteractswithagent,concept:organizationactsinlocation" "Y~_z-concept:country:usa~concept:geopoliticallocationcontainsstate,concept:statecontainscity" "Y~X0~concept:hasofficeincity,concept:cityhasairport,concept:atlocation" "Y~_z-concept:country:countries~concept:generalizationof,concept:countrycities" ] using (pfizer, new_york_city)
• OE @1021 (89.3%) on 14-oct-2016 [ http://www.businesswire.com/news/home/20110125006020/en/Pfizer-Announces-York-City%E2%80%99s-Top-Research-Hospitals http://www.businesswire.com/news/home/20110125006020/en/Pfizer-Announces-York-City%E2%80%99s-Top-Research-Hospitals http://www.businesswire.com/news/home/20110125006020/en/Pfizer-Announces-York-City%E2%80%99s-Top-Research-Hospitals http://en.wikipedia.org/wiki/Pfizer http://www.businesswire.com/news/home/20110125006020/en/Pfizer-Announces-York-City%E2%80%99s-Top-Research-Hospitals  ] using (pfizer, new_york_city)
• united_kingdom (male)
• CPL @1115 (50.0%) on 27-aug-2018 [ "arg1 Central Research in arg2" ] using (pfizer, united_kingdom)
• center (mediatype)
• CPL @1104 (50.0%) on 18-mar-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• center (medicalprocedure)
• CPL @1104 (50.0%) on 18-mar-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• center (mlsoftware)
• CPL @1104 (50.0%) on 18-mar-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• center (monument)
• CPL @1104 (50.0%) on 18-mar-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• center (museum)
• CPL @1104 (50.0%) on 18-mar-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• center (musicalbum)
• CPL @1104 (50.0%) on 18-mar-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• center (nondiseasecondition)
• CPL @1104 (50.0%) on 18-mar-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• new_zealand
• CPL @1107 (50.0%) on 24-may-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, england)
• center (person)
• CPL @1104 (50.0%) on 18-mar-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• chairman (person)
• CPL @1107 (50.0%) on 24-may-2018 [ "arg1 Central Research in arg2" ] using (pfizer, chairman)
• england (person)
• CPL @1107 (50.0%) on 24-may-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, england)
• kent (person)
• CPL @1104 (50.0%) on 18-mar-2018 [ "arg1 Central Research in arg2" ] using (pfizer, kent)
• center (personasia)
• CPL @1104 (50.0%) on 18-mar-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• center (personeurope)
• CPL @1104 (50.0%) on 18-mar-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• new_york (personnorthamerica)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:hasofficeincity" "Y~X0~concept:agentinteractswithagent,concept:agentinteractswithagent,concept:organizationactsinlocation" "Y~_z-concept:country:usa~concept:geopoliticallocationcontainsstate,concept:statecontainscity" "Y~X0~concept:hasofficeincity,concept:cityhasairport,concept:atlocation" "Y~_z-concept:country:countries~concept:generalizationof,concept:countrycities" ] using (pfizer, new_york)
• OE @1104 (100.0%) on 18-mar-2018 [ http://en.wikipedia.org/wiki/Pfizer http://en.wikipedia.org/wiki/Pfizer http://topics.nytimes.com/top/news/business/companies/pfizer_inc/index.html http://topics.nytimes.com/top/news/business/companies/pfizer_inc/index.html  ] using (pfizer, new_york)
• chairman (politicaloffice)
• CPL @1107 (50.0%) on 24-may-2018 [ "arg1 Central Research in arg2" ] using (pfizer, chairman)
• united_kingdom (publication)
• CPL @1115 (50.0%) on 27-aug-2018 [ "arg1 Central Research in arg2" ] using (pfizer, united_kingdom)
• kent (room)
• CPL @1104 (50.0%) on 18-mar-2018 [ "arg1 Central Research in arg2" ] using (pfizer, kent)
• center (shoppingmall)
• CPL @1104 (50.0%) on 18-mar-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• center (skyscraper)
• CPL @1104 (50.0%) on 18-mar-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• uk (sportsteam)
• CPL @1104 (50.0%) on 18-mar-2018 [ "arg1 Central Research in arg2" ] using (pfizer, uk)
• center (sportsteamposition)
• CPL @1104 (50.0%) on 18-mar-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• center (stadiumoreventvenue)
• CPL @1104 (50.0%) on 18-mar-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• connecticut (stateorprovince)
• CPL @1104 (75.0%) on 18-mar-2018 [ "arg1 Global Research and Development in arg2" "arg1 Central Research in arg2" ] using (pfizer, connecticut)
• new_york (stateorprovince)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:hasofficeincity" "Y~X0~concept:agentinteractswithagent,concept:agentinteractswithagent,concept:organizationactsinlocation" "Y~_z-concept:country:usa~concept:geopoliticallocationcontainsstate,concept:statecontainscity" "Y~X0~concept:hasofficeincity,concept:cityhasairport,concept:atlocation" "Y~_z-concept:country:countries~concept:generalizationof,concept:countrycities" ] using (pfizer, new_york)
• OE @1104 (100.0%) on 18-mar-2018 [ http://en.wikipedia.org/wiki/Pfizer http://en.wikipedia.org/wiki/Pfizer http://topics.nytimes.com/top/news/business/companies/pfizer_inc/index.html http://topics.nytimes.com/top/news/business/companies/pfizer_inc/index.html  ] using (pfizer, new_york)
• center (televisionshow)
• CPL @1104 (50.0%) on 18-mar-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• center (tool)
• CPL @1104 (50.0%) on 18-mar-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• center (trainstation)
• CPL @1104 (50.0%) on 18-mar-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• connecticut (university)
• CPL @1104 (75.0%) on 18-mar-2018 [ "arg1 Global Research and Development in arg2" "arg1 Central Research in arg2" ] using (pfizer, connecticut)
• center (visualizableattribute)
• CPL @1104 (50.0%) on 18-mar-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• center (visualizablescene)
• CPL @1104 (50.0%) on 18-mar-2018 [ "arg1 Global Research and Development in arg2" ] using (pfizer, center)
• new_york (visualizablescene)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:hasofficeincity" "Y~X0~concept:agentinteractswithagent,concept:agentinteractswithagent,concept:organizationactsinlocation" "Y~_z-concept:country:usa~concept:geopoliticallocationcontainsstate,concept:statecontainscity" "Y~X0~concept:hasofficeincity,concept:cityhasairport,concept:atlocation" "Y~_z-concept:country:countries~concept:generalizationof,concept:countrycities" ] using (pfizer, new_york)
• OE @1104 (100.0%) on 18-mar-2018 [ http://en.wikipedia.org/wiki/Pfizer http://en.wikipedia.org/wiki/Pfizer http://topics.nytimes.com/top/news/business/companies/pfizer_inc/index.html http://topics.nytimes.com/top/news/business/companies/pfizer_inc/index.html  ] using (pfizer, new_york)
• producesproduct
• development (academicfield)
• CPL @1099 (50.0%) on 23-jan-2018 [ "arg1 debuted arg2" ] using (pfizer, development)
• development (agent)
• CPL @1099 (50.0%) on 23-jan-2018 [ "arg1 debuted arg2" ] using (pfizer, development)
• development (artery)
• CPL @1099 (50.0%) on 23-jan-2018 [ "arg1 debuted arg2" ] using (pfizer, development)
• development (boardgame)
• CPL @1099 (50.0%) on 23-jan-2018 [ "arg1 debuted arg2" ] using (pfizer, development)
• development (building)
• CPL @1099 (50.0%) on 23-jan-2018 [ "arg1 debuted arg2" ] using (pfizer, development)
• development (celltype)
• CPL @1099 (50.0%) on 23-jan-2018 [ "arg1 debuted arg2" ] using (pfizer, development)
• development (charactertrait)
• CPL @1099 (50.0%) on 23-jan-2018 [ "arg1 debuted arg2" ] using (pfizer, development)
• lipitor (chemical)
• Seed
• OE @806 (95.7%) on 23-jan-2014 [   ] using (pfizer, lipitor)
• development (emotion)
• CPL @1099 (50.0%) on 23-jan-2018 [ "arg1 debuted arg2" ] using (pfizer, development)
• development (eventoutcome)
• CPL @1099 (50.0%) on 23-jan-2018 [ "arg1 debuted arg2" ] using (pfizer, development)
• development (male)
• CPL @1099 (50.0%) on 23-jan-2018 [ "arg1 debuted arg2" ] using (pfizer, development)
• development (mlarea)
• CPL @1099 (50.0%) on 23-jan-2018 [ "arg1 debuted arg2" ] using (pfizer, development)
• development (perceptionaction)
• CPL @1099 (50.0%) on 23-jan-2018 [ "arg1 debuted arg2" ] using (pfizer, development)
• development (personalcareitem)
• CPL @1099 (50.0%) on 23-jan-2018 [ "arg1 debuted arg2" ] using (pfizer, development)
• development (physicalaction)
• CPL @1099 (50.0%) on 23-jan-2018 [ "arg1 debuted arg2" ] using (pfizer, development)
• development (physiologicalcondition)
• CPL @1099 (50.0%) on 23-jan-2018 [ "arg1 debuted arg2" ] using (pfizer, development)
• development (profession)
• CPL @1099 (50.0%) on 23-jan-2018 [ "arg1 debuted arg2" ] using (pfizer, development)
• development (programminglanguage)
• CPL @1099 (50.0%) on 23-jan-2018 [ "arg1 debuted arg2" ] using (pfizer, development)
• development (sociopolitical)
• CPL @1099 (50.0%) on 23-jan-2018 [ "arg1 debuted arg2" ] using (pfizer, development)
• mutualproxyfor
• years (building)
• CPL @1112 (50.0%) on 20-jul-2018 [ "arg1 Mexico for four arg2" ] using (pfizer, years)
• CPL @1112 (50.0%) on 20-jul-2018 [ "arg1 Mexico for four arg2" ] using (years, pfizer)
• years (emotion)
• CPL @1112 (50.0%) on 20-jul-2018 [ "arg1 Mexico for four arg2" ] using (pfizer, years)
• CPL @1112 (50.0%) on 20-jul-2018 [ "arg1 Mexico for four arg2" ] using (years, pfizer)
• new (geopoliticallocation)
• CPL @1116 (50.0%) on 06-sep-2018 [ "arg1 Jersey and arg2" ] using (new, pfizer)
• CPL @1116 (50.0%) on 06-sep-2018 [ "arg1 Jersey and arg2" ] using (pfizer, new)
• new (politicaloffice)
• CPL @1116 (50.0%) on 06-sep-2018 [ "arg1 Jersey and arg2" ] using (new, pfizer)
• CPL @1116 (50.0%) on 06-sep-2018 [ "arg1 Jersey and arg2" ] using (pfizer, new)
• new (room)
• CPL @1116 (50.0%) on 06-sep-2018 [ "arg1 Jersey and arg2" ] using (new, pfizer)
• CPL @1116 (50.0%) on 06-sep-2018 [ "arg1 Jersey and arg2" ] using (pfizer, new)
• new (sportsleague)
• CPL @1116 (50.0%) on 06-sep-2018 [ "arg1 Jersey and arg2" ] using (new, pfizer)
• CPL @1116 (50.0%) on 06-sep-2018 [ "arg1 Jersey and arg2" ] using (pfizer, new)
• new (tableitem)
• CPL @1116 (50.0%) on 06-sep-2018 [ "arg1 Jersey and arg2" ] using (new, pfizer)
• CPL @1116 (50.0%) on 06-sep-2018 [ "arg1 Jersey and arg2" ] using (pfizer, new)
• new (traditionalgame)
• CPL @1116 (50.0%) on 06-sep-2018 [ "arg1 Jersey and arg2" ] using (new, pfizer)
• CPL @1116 (50.0%) on 06-sep-2018 [ "arg1 Jersey and arg2" ] using (pfizer, new)
• organizationalsoknownas
• sony (company)
• CPL @1094 (50.0%) on 01-jan-2018 [ "arg1 Music Entertainment and arg2" ] using (pfizer, sony)
• CPL @1094 (50.0%) on 01-jan-2018 [ "arg1 Music Entertainment and arg2" ] using (sony, pfizer)
• sony (publication)
• CPL @1094 (50.0%) on 01-jan-2018 [ "arg1 Music Entertainment and arg2" ] using (pfizer, sony)
• CPL @1094 (50.0%) on 01-jan-2018 [ "arg1 Music Entertainment and arg2" ] using (sony, pfizer)
• superpartoforganization
• firm
• CPL @1116 (50.0%) on 06-sep-2018 [ "arg1 was acquired by arg2" ] using (firm, pfizer)
• synonymfor
• _
• CPL @1094 (50.0%) on 01-jan-2018 [ "arg1 is a registered trademark of arg2" ] using (_, pfizer)
• CPL @1094 (50.0%) on 01-jan-2018 [ "arg1 is a registered trademark of arg2" ] using (pfizer, _)
• inverseofpersonmovedtostateorprovince
• larry
• CPL @1099 (50.0%) on 23-jan-2018 [ "arg1 Miller of arg2" ] using (larry, pfizer)
• teammate
• mcclain
• CPL @1097 (50.0%) on 19-jan-2018 [ "arg1 and Matt arg2" ] using (pfizer, mcclain)
• CPL @1097 (50.0%) on 19-jan-2018 [ "arg1 and Matt arg2" ] using (mcclain, pfizer)